Quality control of gene expression in the mammalian cell nucleus by Custódio, Noélia Maria Fernandes, 1971-
UNIVERSIDADE DE LISBOA 
FACULDADE DE MEDICINA 
 
 
 
 
 
 
 
 
 
 
 
Quality control of gene expression in the 
mammalian cell nucleus 
 
 
 
 
 
 
 
Noélia Maria Fernandes Custódio 
 
 
 
 
 
 
 
 
 
 
 
 
Doutoramento em Ciências Biomédicas 
Especialidade  de Ciências Morfológicas 
 
 
2008
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A impressão desta dissertação foi aprovada pela Comissão Coordenadora 
do Conselho Científico da Faculdade de Medicina de Lisboa 
em reunião de 16 de Outubro de 2007
UNIVERSIDADE DE LISBOA 
FACULDADE DE MEDICINA 
 
 
 
 
 
 
 
 
Quality control of gene expression in the 
mammalian cell nucleus 
 
 
 
 
 
Noélia Maria Fernandes Custódio 
 
 
 
 
Tese orientada pela Professora Doutora Maria Carmo-Fonseca 
 
 
 
 
 
 
 
 
 
 
 
 
Doutoramento em Ciências Biomédicas 
Especialidade  de Ciências Morfológicas 
 
 
2008
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As opiniões expressas nesta publicação são da exclusiva 
 responsabilidade do seu autor
Noélia Maria Fernandes Custódio 
 
 
 
 
 
Controlo de qualidade da expressão génica 
no núcleo de células de mamífero 
 
 
 
 
 
 
Dissertação de Candidatura ao Grau de Doutor em Ciências Biomédicas, 
especialidade de Ciências Morfológicas, apresentada à Faculdade de 
Medicina da Universidade de Lisboa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lisboa, 2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Este trabalho foi parcialmente financiado pela Fundação para a Ciência e a 
Tecnologia, no âmbito do Programa PRAXIS XXI, através da Bolsa de 
Doutoramento PRAXIS XXI/BD/9439/96 
 
 
 
 
 TABLE OF CONTENTS 
 
 
 
 
 
PREFÁCIO................................................................................................................................iii 
RESUMO……………………………………………………………………………....…......vii 
 
PREFACE……………………………………………………………………………….…....xv 
ABSTRACT…………………………………………………………………………..……..xvii 
KEYWORDS....……………………………………………………………………...............xxi 
ABBREVIATIONS……………………………………………………………….………..xxiii 
 
 
 
CHAPTER I  
INTRODUCTION 1 
1. The cell nucleus 3 
2. Gene expression as a multistep process 3 
2.1 Transcription by RNA polymerase II 5 
2.2 Pre-mRNA processing 8 
2.3 Nuclear export and translation 18 
3. Coupling between steps of gene expression 22 
3.1 Connecting transcription with pre-mRNA processing 23 
3.2 Interaction between processing steps 33 
3.3 Coupling transcription and processing with mRNA export 35 
4. Integrating gene expression with nuclear architecture 43 
4.1 The concept of sub-nuclear compartments 43 
4.2 Organisation of RNA polymerase II transcription sites in the nucleus 45 
4.3 Pre-mRNA processing within the nucleus 45 
4.4 Dynamics of mRNA within the nuclear environment 47 
5. Quality control mechanisms of gene expression in the nucleus 48 
5.1 A nuclear turnover pathway for mRNA 49 
5.2 A polyadenylation-dependent checkpoint at the transcription site 50 
5.3 A final checkpoint at the nuclear periphery 52 
6. The human β–globin as a model to study quality control of gene expression 53 
6.1 The human β-globin gene cluster and the LCR 54 
6.2 The LCR/MEL expression system 57 
6.3 Using the LCR/MEL expression system to study quality control of gene  
      expression in the nucleus 58 
7. Goals of the work 59 
 
 
i 
 CHAPTER II  
RESULTS 61 
1. Inefficient processing impairs release of RNA from the site of transcription 63 
2. In vivo recruitment of exon junction complex proteins to transcription sites in 
…mammalian cell nuclei 77 
3. Splicing- and cleavage-independent requirement of RNA polymerase II CTD               
....for mRNA release from the transcription site 91 
4. Abundance of the largest subunit of RNA polymerase II in the nucleus is                     
…regulated by nucleo-cytoplasmic shuttling 103 
 
CHAPTER III  
CONCLUDING REMARKS AND FUTURE PERSPECTIVES 117 
 
REFERENCES 131 
 
 
 
ii 
Prefácio 
PREFÁCIO 
 
 
Nesta dissertação apresentam-se os resultados do trabalho de investigação 
desenvolvido entre os anos de 1997 e 2007 na Faculdade de Medicina da Universidade de 
Lisboa, sob orientação da Professora Doutora Maria Carmo-Fonseca. O trabalho foi iniciado 
no Instituto de Histologia e Embriologia da Faculdade e continuado, desde 2003, na Unidade 
de Biologia Celular do Instituto de Medicina Molecular, Faculdade de Medicina da 
Universidade de Lisboa. 
 
Este trabalho teve como principal objectivo elucidar o mecanismo de controlo de 
qualidade que leva à retenção nuclear dos transcritos do gene da β-globina humana com 
mutações que afectam o processamento do pré-mRNA. 
 
Como previsto no Artigo 40º do Regulamento de Estudos Pós-graduados da 
Universidade de Lisboa (Deliberação nº 961/2003), a presente dissertação encontra-se 
redigida em língua inglesa, contendo um resumo alargado (mais de 1200 palavras) em língua 
portuguesa. 
 
A dissertação encontra-se dividida em três capítulos: no primeiro capítulo - 
Introduction, é feita uma revisão geral sobre as vária etapas da expressão génica com 
principal incidência nas etapas que ocorrem ao nível do núcleo. Inicialmente é feita uma 
descrição de cada uma das etapas e da maquinaria nela interveniente. É dada especial 
relevância às inter-relações que hoje se conhecem entre as várias etapas da expressão génica e 
é feita uma revisão sobre o seu controlo de qualidade ao nível do núcleo. Finalmente 
apresenta-se o modelo utilizado e os principais objectivos deste estudo. 
No segundo capítulo - Results, são apresentados os resultados originais obtidos neste 
estudo sob a forma de artigos publicados.  
Finalmente, no terceiro capítulo - Concluding Remarks and Future Pespectives, são 
realçadas as principais conclusões do trabalho e expostas as perspectivas que se abrem para 
futuros estudos. 
 
 iii
Prefácio 
Como previsto no Decreto de Lei 388/70, art. 8º, parágrafo 2, parte integral dos 
resultados encontra-se publicada nos seguintes artigos: 
 
Custódio, N., Carmo-Fonseca, M., Geraghtly, F., Pereira. S.H., Grosveld, F., 
Antoniou, M. (1999) Inefficient processing impairs release of RNA from the site of 
transcription. EMBO J. 18: 2855-2866. 
 
Custódio, N., Carvalho, C. Condado, I., Antoniou, M., Blencowe, B., Carmo-Fonseca, 
M. (2004) In vivo recruitment of exon junction complex proteins to transcription sites in 
mammalian cell nuclei. RNA 10: 622-633. 
 
Custódio N, Antoniou M, Carmo-Fonseca M. (2006) Abundance of the largest subunit 
of RNA polymerase II in the nucleus is regulated by nucleo-cytoplasmic shuttling. Exp Cell 
Res. 312: 2557-2567. 
 
Custódio, N., Vivo, M., Antoniou, M. and Carmo-Fonseca, M. (2007) Splicing- and cleavage-
independent requirement of RNA polymerase II CTD for mRNA release from the 
transcription site. J. Cell Biol. 179: 199-207. 
 
 
A realização deste trabalho não teria sido possível sem a colaboração de pessoas e 
instituições a quem desejo deixar expressos os meus agradecimentos.  
Em primeiro lugar, gostaria de endereçar um agradecimento especial à Professora 
Doutora Maria Carmo-Fonseca, pelo privilégio que me concedeu ao admitir-me como 
membro da sua equipa de investigação e mais tarde como membro da equipa de docentes de 
Biologia Molecular da Célula. Agradeço-lhe ainda pelas excelentes condições de trabalho que 
me proporcionou e pelo empenho com que sempre orientou o meu trabalho e a minha 
formação científica.  
Ao Professor Doutor J.F. David-Ferreira agradeço o facto de me ter recebido enquanto 
Director do Instituto de Histologia e Embriologia da Faculdade de Medicina da Universidade 
de Lisboa, para a realização do meu estágio de licenciatura. 
Ao Doutor Michael Antoniou agradeço a sua colaboração no trabalho apresentado 
nesta dissertação e o facto de me ter recebido no seu laboratório no Department of 
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Experimental Pathology, Guy’s Hospital Campus, Londres, onde efectuei um estágio de 
alguns meses em 1998 e 99. Os seus conselhos, assim como os dos seus colaboradores Selina 
Raguz e Desmond Chow, foram imprescindíveis à realização de uma parte do trabalho aqui 
apresentado. 
Os trabalhos publicados apresentados nesta dissertação contaram ainda com a 
participação dos seguintes co-autores: Helena Sofia Pereira, Inês Condado, Célia Carvalho, 
Maria Vivo (Instituto de Histologia e Embriologia e Instituto de Medicina Molecular), Finola 
Geraghty, Michael Antoniou (King’s College London School of Medicine, London, UK), 
Frank Grosveld (Erasmus University, The Netherlands), Benjamin J. Blencowe (University of 
Toronto, Canada) a quem agradeço a valiosa contribuição. 
Agradeço à Fundação para a Ciência e a Tecnologia o apoio financeiro que me 
concedeu no âmbito de uma Bolsa de Doutoramento (Bolsa PRAXIS XXI/BD/9439/96) 
durante a fase inicial do trabalho aqui apresentado. 
A todos os meus colegas de trabalho do Instituto de Histologia e Embriologia e mais 
tarde do Instituto de Medicina Molecular, quero agradecer a amizade constante, os conselhos 
sempre úteis e a troca de ideias e conhecimentos que ajudou a ultrapassar muitos obstáculos 
ao longo dos anos. Não posso deixar de expressar aqui uma palavra especial para todos 
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RESUMO 
 
Nos eucariontes, a transcrição dos genes pela RNA Polimerase II (RNA Pol II) origina 
moléculas de RNA mensageiro precursoras (pré-mRNA), sendo necessárias várias etapas de 
processamento até à formação do mRNA funcional que é transportado para o citoplasma, 
onde serve de molde para a síntese proteica. Essas etapas de processamento consistem em três 
processos distintos: na adição de uma trifosfoguanosina metilada na extremidade 5' trifosfato, 
estrutura conhecida como cap; na remoção de sequências não codificantes presentes no pré-
mRNA (intrões) e junção das sequências codificantes flanqueadores (exões), num processo 
designado por splicing; e finalmente na formação da extremidade 3’ do mRNA que consiste 
na clivagem e na adição à extremidade 3’OH resultante, de múltiplos nucleótidos de adenina, 
num processo designado por poliadenilação. Cada uma destas etapas de processamento é 
levada a cabo por uma maquinaria própria. No caso da adição do cap são necessárias três 
enzimas: uma RNA 5’ trifosfatase, uma guanililtransferase e uma metiltransferase. O 
mecanismo de splicing envolve a ligação sequencial ao pré-mRNA de várias partículas 
ribonucleoproteicas nucleares pequenas (snRNP) que, com o auxílio de vários factores 
proteicos, formam uma estrutura complexa denominada spliceossoma. A maquinaria de 
poliadenilação é constituída por vários complexos proteicos, pela polimerase de poly(A) 
(PAP) e pela proteína nuclear de ligação ao poli(A) (PABPN1, anteriormente designada 
PABP2) (revisto por Proudfoot et al., 2002). 
O correcto processamento das moléculas de pré-mRNA é um requisito fundamental 
para o transporte do mRNA para o citoplasma. Existem evidências de que moléculas de pré-
mRNA com mutações nas regiões de consenso 5' e 3' dos seus intrões, que permitem a 
formação do spliceossoma mas que impedem a remoção dos intrões, são retidas no núcleo, 
enquanto que moléculas de pré-mRNA com mutações que não permitem a formação do 
spliceossoma são rapidamente exportadas para o citoplasma (Chang and Sharp, 1989; Hamm 
and Mattaj, 1990; Legrain and Rosbash, 1989). Do mesmo modo, mutações que interferem 
com a correcta poliadenilação do pré-mRNA também impedem a sua exportação para o 
citoplasma (Antoniou et al., 1998). Apesar destes resultados apontarem para a existência, no 
núcleo, de um mecanismo de controlo da qualidade do mRNA exportado, sabe-se muito 
pouco sobre o modo como esse controlo é efectuado. Com o objectivo de compreender o 
mecanismo de controlo de qualidade do mRNA exportado em células de mamífero iniciou-se 
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o estudo da organização intranuclear do RNA da β-globina humana. O gene da β-globina 
humana foi escolhido para este estudo devido ao grande número de mutações pontuais que 
afectam o processamento do pré-mRNA e que estão na base de uma doença genética 
designada por β-talassémia (Antonioiu, 1995). A expressão deste gene está limitada a células 
da linhagem eritróide, durante o processo de diferenciação (Tang et al., 2002). Assim, como 
modelo de estudo, utilizaram-se células de eritroleucemia murina (MEL, Murine 
ErythroLeukemia), que podem ser induzidas a diferenciar-se em cultura e expressar os genes 
específicos das células eritróides, onde se incluem os genes das globinas. Estas células foram 
transfectadas de forma estável com o gene da β-globina humana (βWT) e com mutantes do 
referido gene, nomeadamente com mutações que impedem o splicing do segundo intrão 
(βSM) e uma mutação que impede a poliadenilação (βIVSI). Quando este estudo foi iniciado 
sabia-se que os genes mutados eram transcritos e que o respectivo RNA não se acumulavam 
no citoplasma das células MEL, ao contrário do que acontecia com o mRNA da β-globina 
humana normal (Antoniou et al., 1998). O primeiro objectivo deste estudo foi então 
determinar a localização nuclear dos transcritos mutados. Para alcançar este objectivo foi 
optimizada a técnica de hibridação in situ para detecção dos transcritos do gene da β-globina 
humana nas células MEL. Esta experiência mostrou que os transcritos do gene normal eram 
detectados no núcleo, junto ao local de transcrição e acumulavam-se no citoplasma, enquanto 
que os transcritos dos genes mutados eram detectados apenas junto ao local de transcrição. 
Para avaliar a cinética de libertação do RNA do local de transcrição foram efectuadas 
experiências com o inibidor de transcrição actinomicina D. Este inibidor actua muito 
rapidamente após a sua adição ao meio de cultura (Darnell et al., 1971) e exerce o seu efeito 
através do bloqueio da elongação, uma vez que se intercala nas moléculas de DNA (Reich and 
Goldberg, 1964). Após 5 minutos de tratamento com actinomicina D os transcritos do gene da 
β-globina humana normal deixaram de ser detectados no núcleo, o que sugeriu que o RNA 
previamente transcrito já tinha sido libertado do local de transcrição. Por outro lado, os 
transcritos que têm uma mutação na região de consenso 5' do segundo intrão (βSM), que 
permite a formação do spliceossoma, mas inibe o splicing (Lamond et al., 1987) 
permaneceram junto ao local de transcrição após o tratamento com actinomicina D. Os 
transcritos que não possuem o segundo intrão (βIVSI) e por isso não são poliadenilados 
(Collis et al., 1990) ficaram também retidos no núcleo, junto ao local de transcrição, após o 
tratamento com actinomicina D. Estes resultados mostraram que os transcritos do gene da β-
globina humana são rapidamente libertados do local de transcrição, enquanto que os 
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transcritos que possuem mutações que impedem o splicing e a poliadenilação ficam retidos 
próximo do gene, sugerindo que o mecanismo de controlo de qualidade do mRNA exportado 
actua ao nível do local de transcrição (Custódio et al., 1999). 
O objectivo seguinte foi determinar qual o mecanismo molecular responsável pelo 
controlo de qualidade do mRNA ao nível do local de transcrição. Estudos efectuados na 
última década têm revelado a existência de inúmeras interacções entre a maquinaria de 
transcrição, de processamento do pré-mRNA e de exportação do mRNA para o citoplasma 
(ver Bentley, 2005). Uma das hipóteses colocadas para explicar a retenção dos transcritos com 
mutações junto ao local de transcrição foi a de que neste caso poderia não haver recrutamento 
de proteínas essenciais para a libertação e/ou transporte do mRNA a partir do respectivo gene. 
A outra hipótese colocada foi a de que a retenção poderia ocorrer por intermédio de proteínas 
que estão ligadas aos transcritos nascentes durante o processamento e que se libertam quando 
este se completa, mas que no caso dos mutantes ficam bloqueadas devido ao facto de o 
processamento do pré-mRNA não se completar.  
Para testar a primeira hipótese decidimos estudar o recrutamento, para o local de 
transcrição, de proteínas que se ligam ao mRNA. Assim testamos o recrutamento de proteínas 
que se ligam ao mRNA após o splicing, designadas de proteínas do complexo junção de 
splicing (EJC, exon junction complex), e de factores de exportação do mRNA. Para tal, 
conjugou-se a técnica de hibridação in situ para detecção dos transcritos com a localização 
das proteínas em questão (por imunomarcação com anticorpos específicos ou transfecção para 
expressão de proteína com marcador fluorescente). Assim, efectuou-se detecção de proteínas 
do EJC (REF/Aly, Y14, SRm160, UAP56, RNPS1 e Magoh), de componentes do 
spliceossoma (proteínas Sm e proteína B’’ do snRNP U2) e dos factores de exportação do 
mRNA (NXF1/TAP e p15) simultaneamente com a detecção dos transcritos da β-globina 
humana. Os resultados obtidos indicaram que as proteínas EJC e os componentes do 
spliceossoma são recrutados para os locais de transcrição do gene normal, no entanto, não se 
detectou acumulação dos factores de exportação junto ao local de transcrição. Estes resultados 
sugerem que as proteínas do EJC se ligam estavelmente ao pré-mRNA co-transcricionalmete, 
mas que os factores de exportação se ligam imediatamente antes da libertação dos transcritos 
do gene ou após estes se terem libertado. Quando se efectuou a mesma análise num mutante 
de processamento não se detectou recrutamento para o local de transcrição, nem das proteínas 
do EJC, nem dos componentes do spliceossoma. Estes resultados sugerem que o splicing dos 
transcritos da β-globina é essencial para a acumulação das proteínas do EJC no local de 
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transcrição e possivelmente para o posterior direccionamento para a via de exportação do 
mRNA para o citoplasma (Custódio et al., 2004). Embora os resultados obtidos não descartem 
a hipótese de que o recrutamento eficiente de proteínas do EJC e/ou de factores de exportação 
do mRNA possa contribuir para a libertação do mRNA do local de transcrição, são ainda 
necessários mais estudos para que se possa concluir se estas proteínas desempenham um papel 
essencial neste mecanismo. 
Sabe-se que a associação entre a maquinaria de transcrição e a maquinaria de 
processamento do pré-mRNA é mediada pela extremidade carboxílica da subunidade grande 
da RNA polimerase II (RNA Pol II LS), normalmente designada de CTD (Carboxyl-Terminal 
Domain) (revisto por Bentley, 1999). O CTD da RNA Pol II apresenta uma constituição 
invulgar, sendo formado por repetições em tandem de um heptapéptido com o consenso 
Tirosina-Serina-Prolina-Treonina-Serina-Prolina-Serina, seguido de um motivo C-terminal 
constituído por 10 aminoácidos (Corden et al., 1985). O número de heptapéptidos presentes 
varia entre os eucariontes, apresentando os mamíferos 52 unidades repetitivas (Corden et al., 
1985) e as leveduras apenas 26 (Allison et al., 1985). As primeiras evidências para uma 
ligação entre o CTD e o processamento do pré-mRNA vieram de estudos que apontavam para 
a existência de uma interacção entre determinados factores de splicing (Chabot et al., 1995; 
Kim et al., 1997; Mortillaro et al., 1996), de poliadenilação (McCracken et al., 1997b) e 
capping (McCracken et al., 1997a) com o CTD da RNA Pol II LS. Essas evidências foram 
fortalecidas quando se mostrou que uma forma da RNA Pol II LS com apenas 5 unidades 
repetitivas no CTD não era capaz de assegurar nem o splicing nem o processamento da 
extremidade 3’ do pré-mRNA (McCracken et al., 1997b). Estudos mais recentes mostraram 
que as unidades repetitivas 1-15 e 1-25 são capazes de assegurar o capping, mas não o 
splicing ou a formação da extremidade 3’ do pré-mRNA, enquanto que as unidades 27-52 em 
conjunto com os 10 aminoácidos do domínio C-terminal asseguram o capping, o splicing e o 
processamento da extremidade 3’ (Fong and Bentley, 2001). Foi também mostrado que a 
alteração do motivo C-terminal reduz a eficiência do splicing e da clivagem da extremidade 3’ 
do pré-mRNA (Fong et al., 2003) e impede a libertação do RNA do local de transcrição (Bird 
et al., 2005). 
Tendo em conta estes dados, a hipótese de que a retenção junto ao local de transcrição 
pode ocorrer por intermédio de proteínas que se ligam aos transcritos nascentes e não se 
libertam devido ao bloqueio no processamento do pré-mRNA ganhou um candidato 
preferencial, o CTD da RNA Pol II. Assim, a retenção poderá ocorrer por intermédio da 
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maquinaria de processamento ineficaz ou inactiva que permanece associada ao CTD da RNA 
Pol II, pressupondo-se que a maquinaria de processamento se associa ao CTD durante a 
reacção e se desliga do CTD no final da mesma, permitindo a libertação do RNA para 
posterior transporte para o citoplasma. No caso dos mutantes, em que ocorre associação da 
maquinaria de processamento mas a reacção não se completa devido à mutação, o pré-mRNA 
poderá permanecer ligado ao CTD via essa mesma maquinaria, acabando por ser degradado. 
Para testar esta hipótese a abordagem experimental escolhida consistiu na construção de um 
modelo celular onde a transcrição dos genes é efectuada por uma RNA Pol II com delecção 
parcial do CTD. Esta abordagem é facilitada pela existência de formas da RNA Pol II LS 
resistentes ao inibidor de transcrição α-amanitina, o que permite anular a RNA Pol II 
endógena. Foram estabelecidas linhas celulares estavelmente transfectadas com o gene da 
RNA Pol II LS com 5 repetições no CTD (Δ5), com 31 repetições (Δ31) e com 52 repetições 
(controlo, wild-type). Foi efectuada uma primeira triagem a estas linhas para avaliar a sua 
capacidade de transcrever na presença de α-amanitina. Nenhuma das linhas Δ5 testadas 
apresentou capacidade de transcrever o gene da globina murina β-major na presença de α-
amanitina. Este resultado foi inesperado, uma vez que este mutante já tinha sido utilizado em 
estudos anteriores, onde foi mostrado que apresentava capacidade de transcrever o gene da β-
globina humana sob controlo do promotor SV40 (McCracken et al., 1997b). No entanto, 
estudos posteriores onde se analisou a capacidade transcricional da RNA Pol II Δ5 por run-on 
em mais de 500 genes, indicaram que a este mutante não é funcionalmente activo para a 
transcrição de genes endógenos (Meininghaus et al., 2000). Estes resultados impossibilitaram 
a utilização dos clones Δ5 nos estudos posteriores. Das linhas Δ31 e wild-type que 
apresentaram capacidade de transcrever na presença de α-amanitina foi seleccionada uma para 
transfecção com o gene da β-globina humana. Cada uma das linhas foi transfectada quer com 
a versão normal do gene (βWT), quer com uma versão que possui uma mutação de splicing 
(βSM) para a qual se mostrou anteriormente que há retenção do respectivo RNA junto ao 
local de transcrição. Os transcritos da β-globina humana foram detectados no núcleo das 
células transfectadas como um foco que corresponde ao RNA junto do local de transcrição. 
Quando se efectuou o tratamento com o inibidor de transcrição actinomicina D os resultados 
indicaram que uma grande proporção dos transcritos βWT feitos pela RNA Pol II Δ31 
ficavam retidos no local de transcrição. Apesar deste resultado, observou-se recrutamento de 
proteínas do EJC, incluindo Aly/REF, Y14 e SRm160 para os locais de transcrição. Uma 
análise bioquímica dos transcritos βWT feitos pela RNA Pol II Δ31 indicou que sofriam 
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splicing e processamento na extremidade 3’ correctamente. Estes resultados indicam que a 
RNA Pol II LS com apenas 31 unidades repetitivas é capaz de transcrever mas não permite a 
libertação eficiente do mRNA do local de transcrição. Isto sugere que a estrutura do CTD é 
importante para a libertação do mRNA do local de transcrição, possivelmente porque assegura 
o recrutamento de proteínas importantes para uma maturação final do mRNA após o splicing 
e o processamento da extremidade 3’, que o transforma numa partícula ribonucleoproteíca 
competente para ser exportada. Propomos assim que as unidades repetitivas em falta no 
mutante Δ31 da RNA Pol II poderão ser essenciais para o recrutamento destas proteínas 
(Custódio et al., 2007).  
A RNA Pol II eucariota é uma enzima complexa, composta por 12 sub-unidades 
distintas, que se encontra presente na célula em níveis relativamente baixos (revisto por 
Shilatifard et al., 2003). A transcrição do pré-mRNA pela RNA Pol II envolve ciclos de 
fosforilação e desfosforilação do CTD da sua maior subunidade. O CTD encontra-se 
hipofosforilado quando a RNA Pol II se liga ao complexo de pré-iniciação e assume uma 
forma hiperfosforilada quando o transcrito tem cerca de 25 bases (O'Brien et al., 1994). A 
primeira fosforilação ocorre na Serina que se encontra na posição 5 do heptapéptido e durante 
a elongação a Serina na posição 2 é fosforilada (Komarnitsky et al., 2000; Lu et al., 1991). 
Pelas razões já mencionadas, estabelecemos linhas celulares murinas que expressam uma 
forma da RNA Pol II LS resistente ao inibidor de transcrição α-amanitina. Foi efectuada uma 
primeira triagem a essas linhas celulares para seleccionar aquelas que apresentavam a 
capacidade de sobreviver e transcrever na presença da α-amanitina, assegurando que nessas 
linhas a RNA Pol II LS exógena é funcional. Com o objectivo de estudar a localização sub-
celular da RNA Pol II LS seleccionaram-se duas linhas com níveis diferentes de expressão da 
subunidade exógena. Resultados de imunomarcação e western-blotting indicaram que a  RNA 
Pol II LS sobre-expressa se encontra predominantemente hipofosforilada e se acumula 
sobretudo no citoplasma. A forma activa (fosforilada na Serina 2 do heptapéptido), pelo 
contrário, encontra-se exclusivamente no núcleo, em níveis constantes, independentemente do 
grau de sobre-expressão da proteína. A presença, no citoplasma, da RNA Pol II LS sobre-
expressa foi descrita num outro estudo onde se procedeu à sobre-expressão de uma forma 
conjugada à proteína fluorescente EGFP (Sugaya et al., 2000). Este resultado pode ser 
explicado por uma importação ineficiente para o núcleo do excesso de proteína produzida no 
citoplasma, ou por o excesso de  proteína que é importado para o núcleo ser posteriormente 
exportado para o citoplasma. Para investigar a possibilidade da RNA Pol II LS poder 
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deslocar-se do núcleo para o citoplasma comparámos a distribuição sub-celular das formas 
endógena e exógena sobre-expressa, na presença de leptomicina B (LMB), um inibidor de 
exportação nuclear dependente do transportador CRM1 (Fornerod et al., 1997; Kudo et al., 
1999). Os resultados indicaram que o LMB diminui a acumulação citoplasmática da proteína 
sobre-expressa e aumenta os níveis nucleares da proteína endógena. Estes resultados 
indicaram, pela primeira vez, que a RNA Pol II LS tem a capacidade de efectuar um 
mecanismo de vai-e-vem entre o núcleo e o citoplasma. Propomos que este mecanismo 
poderá ser um meio a que a célula recorre para regular o número do moléculas desta sub-
unidade presentes no núcleo, de modo a manter uma relação equilibrada das várias sub-
unidades e assim assegurar a formação de complexos de transcrição funcionalmente activos 
(Custódio et al., 2006).  
Em conclusão, o trabalho apresentado nesta dissertação foi pioneiro na identificação 
de um mecanismo de controlo de qualidade do mRNA, que actua ao nível do local de 
transcrição, no núcleo de células de mamífero (Custódio et al., 1999). Este mecanismo evita 
que moléculas de pré-mRNA com mutações que impedem o seu correcto processamento 
cheguem ao citoplasma, onde poderiam original proteínas defeituosas com consequências 
negativas quer para a célula quer para o organismo. O trabalho apresentado foi também o 
primeiro a mostrar a importância da libertação do mRNA do local de transcrição, actualmente 
considerada uma etapa importante da síntese do mRNA (ver Vasudevan and Peltz, 2003). 
Estudos efectuados em S. Cerevisiae vieram mostrar que um mecanismo de controlo de 
qualidade semelhante também funciona em levedura, onde transcritos com defeitos na 
poliadenilação ficam retidos no núcleo, ao nível do local de transcrição (Hilleren et al., 2001; 
Jensen et al., 2001b; Libri et al., 2002; Thomsen et al., 2003). O trabalho aqui apresentado 
contribuiu ainda para a compreensão do mecanismo responsável pela retenção dos transcritos 
com defeitos no processamento junto ao local de transcrição. Mostrámos que estes transcritos 
não são capazes de recrutar eficientemente proteínas do complexo junção de splicing 
(Custódio et al., 2004) e que o CTD da RNA Pol II desempenha um papel importante na etapa 
de libertação do mRNA do local de transcrição (Custódio et al., 2007). 
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ABSTRACT 
 
 
Protein-encoding genes are transcribed in the nucleus by RNA polymerase II as 
precursor RNAs that undergo extensive processing before being translocated to the cytoplasm 
for translation by the ribosomes. This spatial and temporal separation between RNA and 
protein synthesis offers an immense opportunity for regulation and quality control. 
When this study was initiated it was known from biochemical studies that human β-
globin (HBB) transcripts with mutations that impaired splicing or 3’ end formation were 
unable to be exported to the cytoplasm, a phenotype identical to that seen in β-thalassemia 
patients harbouring similar mutations (Antoniou et al., 1998). This result was consistent with 
the retention in the nucleus of incorrectly processed transcripts. Based on this initial 
observation we hypothesised the existence of a quality control mechanism to retain the 
incorrectly processed transcripts in the nucleus and proposed to elucidate the mechanism 
responsible for the observed retention. The first goal of this work was to determine the 
intranuclear localisation of the retained transcripts. To address this we used as a model system 
murine erythroleukemia (MEL) cells stably transfected with either wild-type or processing 
mutant HBB genes. The experimental approach was based on the direct visualisation of both 
normal and defective HBB transcripts using fluorescence in situ hybridisation and confocal 
microscopy. Nuclear transcripts of both wild-type and mutant HBB genes were detected only 
as intranuclear foci co-localising with the template gene locus. To determine the kinetics of 
transcript release from the site of transcription the cells were treated with the transcriptional 
inhibitors actinomycin D, α-amanitin and DRB. These drugs induced the rapid disappearance 
of nuclear foci corresponding to wild-type HBB RNA. In contrast, pre-mRNA mutants 
defective in either splicing or 3’ end formation and which fail to be transported to the 
cytoplasm were retained at the site of transcription. These results indicated that the quality 
control mechanism responsible for the nuclear retention of incorrectly processed transcripts 
operates at the site of transcription and suggest that splicing and 3’ end processing are rate 
limiting for release of mRNA from the transcription site.  
The next goal of this work was to determine the molecular players involved in the 
quality control mechanism that operates at the transcription site. Studies over the past years 
have indicated that there is extensive coupling between transcription, pre-mRNA processing 
and nuclear export of mRNA (reviewed by Bentley, 2005). One hypothesis to explain the 
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retention of the mutant transcripts could be the absence of recruitment of proteins essential for 
the release and/or transport of the transcripts from the gene locus. Alternatively, the retention 
could be mediated by proteins that are bound to the nascent transcripts and become stalled due 
to incomplete processing. 
To test the first hypothesis we decided to study the recruitment of exon junction 
complex (EJC) proteins and mRNA export factors to the retention sites in the nucleus. To 
achieve this we visualised the distribution of EJC proteins and RNA export factors relative to 
the sites HBB transcription in the nucleus. Using in situ hybridisation and confocal 
microscopy, we observed accumulation of EJC proteins (REF/Aly, Y14, SRm160, UAP56, 
RNPS1 and Magoh) and core spliceosome components (U snRNPs) at sites of wild-type HBB 
transcription. This suggests that EJC proteins bind stably to pre-mRNA co-transcriptionally. 
No concentration of the export factors NXF1/TAP or p15 was detected on nascent transcripts, 
arguing that in mammalian cells these proteins bind the mRNA shortly before or after release 
from the sites of transcription. Contrasting with the results obtained in MEL cells expressing 
wild-type HBB transcripts, mutant pre-mRNA defective in splicing and 3’ end processing do 
not co-localise with SRm160, REF, UAP56 or Sm proteins. These results suggest that the 
accumulation of EJC proteins at transcription sites requires efficient processing of the nascent 
pre-mRNA. Although the results obtained do not discard the hypothesis that efficient 
recruitment of EJC proteins and/or export factors may contribute to the release of the 
transcripts from the transcription site, further studies are required to conclusively show or 
discard the involvement of these proteins in transcription site release. 
In the second hypothesis the best candidate to mediate the retention is the carboxyl-
terminal domain (CTD) of the largest subunit of RNA polymerase II (RNA Pol II LS). The 
mammalian CTD comprises 52 heptad repeats followed by a terminal 10 amino acid motif 
(Corden et al., 1985). Several reports in the last decade showed that both splicing and 3’ end 
processing factors can associate with the CTD of RNA Pol II (reviewed by Bentley, 2005). 
Since the processing mutants analysed are able to assemble some processing machinery, the 
release of the transcripts could be blocked by the stalled or abnormal processing machinery 
associated with the CTD. In order to test this hypothesis we generated cell lines that express 
either the wild-type HBB gene or a mutant version defective in splicing and an α-amanitin 
resistant form of RNA Pol II LS with either 52 (wt), 31 (Δ31) or 5 (Δ5) repeats of the CTD. 
When these cells were treated with actinomycin D to stop transcription the results showed that 
a large proportion of the wild-type HBB transcripts made by RNA Pol II with only 31 CTD 
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repearts were retained at the site of transcription. Despite this result we observed recruitment 
of several EJC proteins, includind Aly/REF, Y14 and SRm160 to the transcription sites and 
RNase protection assays showed that the HBB transcripts produced by RNA Pol II LS Δ31 are 
correctly spliced and 3’ end cleaved. These results show that the form of RNA Pol II LS with 
only 31 repeats of the CTD is competent in transcription and processing but fails to allow the 
efficient release of the transcripts from the transcription site. These results provide evidence 
that mRNA release from the transcription site requires the heptad repeat structure of the CTD 
and we propose that the missing heptads in the truncated CTD mutant are required for binding 
of proteins implicated in a final co-transcriptional maturation of spliced and 3’ end cleaved 
mRNAs into export-competent ribonucleoprotein particles. 
Eukaryotic RNA polymerase II is a complex enzyme composed of 12 distinct subunits 
that is present in cells in low abundance (reviewed by Shilatifard et al., 2003). Transcription 
of mRNA by RNA polymerase II involves a phosphorylation/ dephosphorylation cycle of the 
CTD of the enzyme’s largest subunit. The hypophosphorylated form assembles into pre-
initiation complexes and the CTD becomes first phosphorylated on Serine at position 5 of the 
heptad repeat and during elongation on Serine at position 2 (Komarnitsky et al., 2000; Lu et 
al., 1991). As mentioned before we have generated stable murine cell lines expressing an α-
amanitin resistant form of RNA Pol II LS. The cell lines generated were screened for survival 
and transcription in the presence of α-amanitin ensuring the functionality of the exogenous 
subunit. To characterise these cell lines we studied the localisation of the exogenous subunit 
and observed that over-expressed RNA Pol II LS was predominantly hypophosphorylated, 
soluble and accumulated in the cytoplasm in a CRM1-dependent manner. Our results further 
showed that the transcriptionally active form of RNA Pol II LS containing phosphoserine in 
position 2 of the CTD repeats was restricted to the nucleus and its levels remained remarkably 
constant. These results suggest that the nuclear-cytoplasmic distribution of RNA Pol II LS 
may be regulated by shuttling and we propose that this may provide a mechanism to control 
the pool of RNA polymerase subunits that is accessible for assembly of a functional enzyme 
in the nucleus.  
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Introduction 
1. The cell nucleus 
 
The nucleus is the hallmark of all eukaryotic cells. It houses the genome of the cell 
serving as the repository of genetic information and functioning as the control center of the 
cell. The nuclear envelope, a double membrane that can be regarded as a specialized 
extension of the endoplasmic reticulum (ER), separates the contents of the nucleus from the 
cytoplasm and provides the structural framework of the nucleus (see Cooper and Hausman, 
2007). Many essential processes take place in the cell nucleus, including DNA replication, 
repair and recombination as well as the initial steps of gene expression (transcription and 
RNA processing). Only the final stage of gene expression (translation) takes place in the 
cytoplasm (Cooper and Hausman, 2007). Prokaryotes do not have a nucleus but carry out 
many of the processes that take place inside the nucleus in eukaryotic cells. So what 
functional advantages can the nucleus bring to a cell? By separating the genome from the 
cytoplasm, the nuclear envelope provided an opportunity for the evolution of new regulatory 
possibilities for gene expression that are unique to eukaryotes. For example, whereas 
prokaryotic mRNAs are translated while their transcription is still in progress, eukaryotic 
mRNAs undergo extensive posttranscriptional processing before being transported to the 
cytoplasm for translation (Cooper and Hausman, 2007). This spatial and temporal separation 
between transcription and protein synthesis offers new opportunities for regulation and opens 
a new window for the control of the quality of gene expression.  
 
2. Gene expression as a multistep process 
 
Gene expression can be defined as the process by which the genetic instructions of the 
DNA are transformed into functional proteins in a cell. Eukaryotic gene expression is a 
complex multistep process that requires several complex cellular machines. Each machine is 
responsible for a specific step in this process, which includes transcription, several precursor 
messenger RNA (pre-mRNA) processing steps (5’ capping, splicing, 3’ end processing and 
editing), export of the mature mRNA to the cytoplasm and translation into protein sequence 
(Figure 1). Identifying the protein components of each of this cellular machines and 
understanding how they work has been a major goal of molecular biologists for the last 25 
years. For that purpose, each of the major steps outlined above has been carried out 
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independently in vitro. However, in the last decade numerous studies have provided evidence 
that they are not independent reactions in vivo. In contrast to a simple linear assembly line in 
which the transcript is made and passes from one processing reaction to the next, it is now 
clear that the processing reactions are co-transcriptional and interlinked in such a way that 
they influence one another’s specifically and efficiently. The emerging picture now is that a 
complex and extensively coupled network exists to coordinate the activities of the several 
gene expression machines (reviewed in Hirose and Manley, 2000; Maniatis and Reed, 2002). 
The goal of this section is to introduce the major steps in gene expression as well as 
the major players in each one of the steps. The connections between them will be the focus of 
section 3. 
 
 
 
Figure 1 - The multiple steps of gene expression. The different steps in the pathway from 
gene to protein include transcription (initiation, elongation and termination), several precursor 
messenger RNA (pre-mRNA) processing steps (5’ capping, splicing and 3’ end processing), 
export of the mature mRNA to the cytoplasm and translation into protein sequence. In the 
figure the mRNA is represented by a green line and the introns by a yellow line. The cap 
binding complex (CBC) added to the 5’ end of the mRNA is represented by a purple oval, the 
splicing machinery by a green oval and the 3’ end processing machinery by a red oval. The 
blue ovals on the mRNA represent the several proteins that bind to it forming a messenger 
ribonucleoprotein particle (mRNP). The ribosome is represented by two pink ovals and the 
nascent peptide by a blue line (see text for more details). 
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2.1 Transcription by RNA polymerase II 
 
Transcription, the DNA-directed synthesis of RNA, is the first step in the sequence of 
events that lead to gene expression. The many thousands of genes coding for proteins in 
eukaryotes are transcribed by the RNA polymerase II (RNA Pol II) transcription machinery. 
In a simplistic view, this machinery can be divided in three major components: the 12-subunit 
polymerase (Figure 2A), capable of synthesizing RNA and proofreading the nascent 
transcript; a set of five general transcription factors (GTFs), denoted TFIIB, -D, -E, -F and -H, 
which are responsible for promoter recognition and for unwinding the promoter DNA; and the 
Mediator complex, composed of 20 subunits, which transduces regulatory information from 
activator and repressor proteins to the RNA polymerase and is unique to eukaryotes (reviewed 
in Boeger et al., 2005; Woychik and Hampsey, 2002). The RNA polymerase can be regarded 
as the core of the machinery because it is the platform upon which all the components are 
assembled. The transcription machinery is composed of a total of nearly 60 subunits and a 
mass of approximately 3 million Daltons (reviewed in Boeger et al., 2005). 
 The transcription cycle can be divided mechanistically in three basic stages: initiation, 
elongation and termination (Figure 2B). During each of these stages, RNA Pol II associates 
transiently with many different factors. Initiation involves the binding of transcription factors 
and RNA Pol II to DNA sites adjacent to the start site of transcription (the promoter regions) 
and the onset of RNA synthesis. After productive initiation, transcription proceeds into 
elongation mode and this is accompanied by a partial disassembly of the initiation complex 
and the association with elongation factors, which enable efficient production of long 
transcripts. In this stage the polymerase moves 5’ to 3’ along the DNA and makes an RNA 
copy of the gene. Finally, the termination stage involves release of the transcripts from RNA 
polymerase and release of the polymerase from the DNA template, allowing recycling of the 
polymerase and preventing it from perturbing promoters of genes located downstream from 
the transcription unit (reviewed by Howe, 2002; Orphanides and Reinberg, 2002).  
The largest of the 12 subunits of RNA Pol II possesses a unique domain, not related to 
regions of any known protein, at its carboxyl terminus, termed the carboxyl-terminal domain 
(CTD) (Figure 2A). The CTD consists of heptapeptide repeats with the consensus Tyr1-Ser2-
Pro3-Thr4-Ser5-Pro6-Ser7 (Corden et al., 1985), which has been conserved through evolution 
(Allison et al., 1988; Barron-Casella and Corden, 1992). The number of repeats varies among 
species, ranging from 26-27 in yeast (Allison et al., 1985) to 52 in mammals (Corden et al., 
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1985). The CTD is rich in potential phosphoacceptor amino acid residues and undergoes a 
cycle of phosphorylation and dephosphorylation during the transcription cycle (Figure 2B) 
(for reviews see Howe, 2002; Kobor and Greenblatt, 2002).  
 
 
 
Figure 2 - RNA Polymerase II and the transcription cycle. (A) Model of the complete 12-
subunit RNA Polymerase II (Armache et al., 2003; Bushnell and Kornberg, 2003). The view 
is from the top. Cyan spheres and a pink sphere depict eight zinc ions and an active site 
magnesium ion, respectively. The red arrow indicates the direction of RNA exit. A key to 
subunit colour is shown on the left with subunits numbered 1-12. The carboxyl-terminal 
domain (CTD) of the largest subunit of RNA polymerase II (RNA Pol II LS, subunit 1) is 
shown in a β-spiral model (Meinhart and Cramer, 2004). The CTD is connected to the 
structured core of RNA Pol II with the mobile linker of approximalely 90 amino acid residues 
in length. Adapted from (Cramer, 2004; Meinhart and Cramer, 2004). (B) CTD 
phosphorylation and the transcription cycle. After recycling the “free” RNA Pol II core 
enzyme is not phosphorylated on the CTD. It may assemble with coactivators such as the 
mediator complex (Med) thus forming a holoenzyme. Premature CTD phosphorylation by 
CDK8 prevents the assembly of RNA Pol II on the promotor. For pre-initiation the 
unphosphorylated RNA Pol II core or holoenzyme assembles onto the promoter sequences 
with general transcription factors (TFIIs) thus forming a pre-inititiation complex of 
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transcription. The CTD is phosphorylated on serines at position 5 (5P) by the CDK7 subunit 
of TFIIH. Initiation follows and transcription begins. The phosphorylated CTD recruits the 
capping enzymes (dark blue oval) and the nascent transcript (geen line) is capped at its 5’ end 
(purple oval). During elongation the CTD is phosphorylated on serines at position 2 (2P) by 
the CDK9 subunit of the positive transcription elongation factor (P-TEFb) which is required 
to remove the block opposed by the DSIF/NELF factors and elongate transcription. The 
phosphorylated CTD recruits the splicing machinery (green oval) to remove introns (yellow 
line) and finally recruits the cleavage and polyadenylation factors (red oval) that cleave the 
transcript and add a poly(A) tail at its 3’ end. This step signals transcription to terminate and 
RNA Pol II falls off its DNA template. The resulting mRNA is exported to the cytoplasm. 
The blue ovals on the mRNA molecules represent proteins that are bound to the mRNA 
forming a messenger ribonucleoprotein particle (mRNP). To be recycled for another 
transcription round, RNA Pol II is dephosphorylated by the FCP1 CTD phosphatase. Adapted 
from (Palancade and Bensaude, 2003). 
 
RNA Pol II with a hypophosphorylated CTD is recruited to promoters (Lu et al., 
1991). Shortly after transcription begins, the CTD becomes phosphorylated on Ser5. This 
modification signals the polymerase to clear the promoter and shift into an elongation mode. 
During the elongation stage of the transcription cycle, phosphorylation of Ser2 predominates 
(Komarnitsky et al., 2000). During or after transcription termination, the CTD is 
dephosphorylated by CTD phosphatases, the best studied of which is FCP1, resulting in 
recycling of the largest subunit of RNA Pol II (Figure 2B) (Cho et al., 1999; Kobor et al., 
1999).  
 The high-resolution crystal structure of RNA Pol II has provided detailed insight into 
how a catalytically active polymerase is structured and has revealed important aspects of its 
function (reviewed in Boeger et al., 2005; Woychik and Hampsey, 2002). It is now known 
that the RNA leaves the polymerase active center cleft via the exit tunnel and then disengages 
from the enzyme surface. When the RNA reaches lengths if 26 and 29 nt, its 5’ end associates 
with RNA Pol II at the base of the dock domain (Andrecka et al., 2008). Interestingly, the 
CTD was shown to be placed near the exit tunnel (Cramer et al., 2001; Douziech et al., 1999) 
and the RNA was shown to extend toward the linker connecting to the CTD (Andrecka et al., 
2008). These structural observations are consistent with the coupling of transcription with the 
processing events and to the role of the CTD as the major key player in this coupling, as will 
be discussed in detail in section 3.  
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2.2 Pre-mRNA processing  
 
In eukaryotes, before a gene transcript is ready to be transported out of the nucleus, it 
has to undergo three major processing events to produce the fully translatable mRNA. These 
comprise the acquisition of a cap structure at the 5’ terminus, the splicing out of non-coding 
intervening sequences (introns) from the pre-mRNA, and the generation of a 3’ end, usually 
modified by the addition of a poly(A) tail. Some transcripts are also subject to an additional 
processing event termed RNA editing. 
 
Capping 
The 5’ end of the pre-mRNA is modified soon after its synthesis, when the transcript is 
about 25–30 nucleotides in length, by the addition of 7-methyl guanosine, usually called the 
cap structure (Coppola et al., 1983; Moteki and Price, 2002; Rasmussen and Lis, 1993). The 
addition of the cap structure is carried out by three enzymatic activities in a process known as 
capping (for a review see Gu and Lima, 2005). First, RNA 5’-triphosphatase hydrolyses the 
triphosphate of the first nucleotide to a diphosphate. Then, RNA guanylyltransferase catalyses 
the fusion of a GMP moiety from GTP to the diphosphate end of the pre-mRNA. To finalize 
the cap structure, the RNA-(guanine-7) methyltransferase adds a methyl group to the N7 
position of the transferred GMP to form the m7G(5’)ppp(5’)N cap. In metazoans, both the 
RNA 5’-triphosphatase and the RNA guanylyltransferase activities are part of the same 
polypeptide at the N-terminus and C-terminus, respectively, called the capping enzyme. In 
Saccharomyces cerevisiae (S. cerevisiae), the capping enzyme consists of two polypeptides, 
RNA triphosphatase (Cet1) and RNA guanylyltransferase (Ceg1), which form a heterodimer 
(reviewed by Shuman, 2001). 
The initial cap structure is recognised by the cap binding complex (CBC), which 
contains two proteins, CBP20 and CBP80. The cap structure bound to CBC is believed to 
play a major role in the stabilization of the mRNA, since it provides an obstacle for 5’ to 3’ 
exonucleases. Upon export through the nuclear pore complex, the nuclear cap binding 
proteins are replaced by the cytoplasmic translation initiation factor, eIF-4E. In the cytoplasm, 
cap bound to eIF-4E and other translation initiation factors enhances translation by promoting 
the engagement of the ribosomal subunits with the mRNA (see Mitchell and Tollervey, 2001). 
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Splicing 
In the majority of mammalian genes the coding sequences are interrupted by non-
coding intervening sequences (introns) that must be removed from the primary transcript (pre-
mRNA) in order to generate a mature functional mRNA for translation (for a review see 
Sharp, 2005). In humans, a typical pre-mRNA contains seven or eight introns (Lander et al., 
2001). The precise removal of the introns and joining of the coding sequences (exons), by a 
process known as splicing, is a critical step in gene expression. The splicing reaction is carried 
out by a large macromolecular complex termed the spliceosome. This is a highly dynamic and 
complex molecular machine whose composition and structure undergoes several 
rearrangements during each cycle of splicing. To date, two spliceosomes of unique 
composition have been characterised. The first one to be identified, now called U2-dependent 
or major spliceosome, is found in all eukaryotes and splices the most commonly encountered 
class of introns (the U2-type introns). It is composed of five small nuclear ribonucleoprotein 
particles (snRNPs; U1, U2, U4, U5 and U6), each of them containing a single uridine-rich 
small nuclear RNA (snRNA) that is associated to a common core of Sm proteins and other 
proteins specific of each particular snRNP. This spliceosome contains also a large number of 
non-snRNP proteins, known as splicing factors that exert auxiliary functions in the splicing 
reaction (reviewed by Jurica and Moore, 2003). The major class of non-snRNP proteins are 
the serine-arginine (SR) proteins, characterised by the presence of one or two RNA-binding 
domains and a carboxyl-terminal SR-rich domain (RS-domain) (Graveley, 2000). A less 
abundant spliceosome was discovered more recently in a subset of eukaryotes and is termed 
U12-dependent or minor spliceosome. This consists of the U11, U12, U5 and U4atac/U6atac 
snRNPs and an unknown number of non-snRNP proteins. Members of the SR protein family 
have been shown to function also in the U12-dependent splicing. Both the major and the 
minor spliceosomes coexist in eukaryotic cells and pre-mRNAs containing both types of 
introns serve as substrates for both splicing machineries. Although U12-type introns represent 
less than 1% of all introns present in human cells, they are found in genes carrying out 
essential cellular functions (for a review see Will and Luhrmann, 2005). It was recently 
reported that the two splicing pathways (minor and major) are spatially separated in the cell. 
In situ hybridisation on tissue sections from adult zebrafish and in mammalian cultured cells 
revealed a perinuclear and cytoplasmic staining for the U12 and U6atac, compared to the 
well-established nuclear distribution of the U2 snRNA of the major spliceosome. Functional 
analysis revealed that the cytoplasmic minor spliceosome is active and pointed to a role in cell 
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proliferation (Konig et al., 2007). U2-dependent splicing was also reported in the cytoplasm 
of platelets and dendritic cells but the full functional and physiological relevance of 
cytoplasmic splicing is not entirely clear yet (Denis et al., 2005; Glanzer et al., 2005).  
The spliceosome acts through RNA-RNA, RNA-protein and protein-protein 
interactions to recognise the exon-intron junctions and catalyse removal of the introns and the 
joining of the exons in the correct order (see Faustino and Cooper, 2003). There are four short 
sequences that define an intron: the exon-intron junction at the 5’ and 3’ ends of the introns 
(5’ and 3’ splice sites), the branch point sequence, which includes an adenosine residue and 
the polypyrimidine tract (Py tract) that precedes the 3’ splice site (see Ast, 2004). Different 
splice sites and branch point sequences are found in U2- and U12- type introns. U2- type 
introns of higher eukaryotes have the sequence AG/GURAGU at the 5’ splice site, CURACU 
at the branch point sequence and YAG/G at the 3’ splice site (where / denotes an exon-intron 
boundary, A is the branchpoint adenosine, R is a purine and Y a pyrimidine). The vast 
majority of U2-type introns have GU and AG dinucleotides at their 5’ and 3’ ends, 
respectively (Figure 3A) (Will and Luhrmann, 2005). By comparison, consensus sequences 
delineating the U12-type 5’ splice site –A(or G)UAUCCUUU– and branch point sequence –
UCCUUAACU– are longer and more tightly constrained. The 3’ splice sites of U12-type 
introns are typically denoted by YAC/ or YAG/, but various other dinucleotides can serve as 
U12- type 3’ splice sites. Similarly to U2-type introns present in yeast, U12-type introns lack 
a polypyrimidine tract. Because the first set of U12-type introns identified contained the 
dinucleotides AT and AC at their 5’ and 3’ ends, respectively, they were originally referred to 
as ATAC introns. Further studies, however, revealed that some U2-type introns also end in 
AT-AC and a large number of U12-type introns also end in GT-AG (see Will and Luhrmann, 
2005). The splicing consensus sequences are short and weakly conserved, thus the splice site 
recognition requires additional RNA sequences that can be present in both introns or exons 
and function as splicing enhancers or repressors modulating the ability of the spliceosome to 
recognise nearby splice sites (reviewed by Matlin et al., 2005). In most organisms, exons or 
introns are recognised as a unit in “exon definition” for short exons or “intron definition” for 
short introns (Robberson et al., 1990). 
In chemical terms, the splicing reaction involves two trans-esterification reactions and 
the U2-type and U12-type introns appear to be removed by an identical mechanism. First the 
2’OH group of the branch point adenosine acts as a nucleophile to attack the phosphate at the 
5’ splice site, and trans-esterification results in a free 5’ exon and a lariat-shaped molecule 
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consisting of the intron sequences and the 3’ exon. In the second reaction, the 3’OH group of 
the free 5’ exon attacks the phosphate at the 3’ end of the intron. The subsequent trans-
esterification results in the fusion of the two exon sequences and the release of the lariat-
shaped intron (see Proudfoot et al., 2002; Will and Luhrmann, 2005).  
 
 
 
Figure 3 - Splicing of U2-type introns. (A) Schematic representation of a U2-type intron 
with its splicing consensus sequences; 5’ and 3’ splice sites, branch point (BP) and 
polypyrimidine (Py) tract. The intron is flanked by two exons (blue and red), the branching 
adenosine is underlined and highlighted in red, R is a purine and Y a pyrimidine. (B) 
Simplified view of the spliceosome cycle for U2-type introns. Only the snRNPs U1, U2, U4, 
U5 and U6 and the splicing factors SF1, U2AF65 and U2AF35 are shown. Different 
spliceosome conformations can be found at specific time points and purified as stable (E, A, B 
and C) complexes. Splicing proceeds through two trans-esterification reactions (red arrows) 
within the active spliceosome complex. After the second splicing reaction the mRNA is 
released, the post-spliceosomal complex containing the excised intron and the U2, U5 and U6 
snRNPs disassembles and the snRNPs are recycled for new rounds of splicing (see text for 
more details) (Ast, 2004; Jurica and Moore, 2003; Will and Luhrmann, 2005). 
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The dissection of the splicing reaction through in vitro studies gave rise to the 
knowledge we have today about the spliceosome cycle for U2-type introns. In these 
experiments, splicing is uncoupled from other pre-mRNA processing events and the 
spliceosome assembly proceeds through a stepwise series of assembly events giving rise to 
short-lived intermediate stages, named E, A, B and C complexes (Figure 3B).  
The initial events of spliceosome assembly require interaction of the U1 snRNA with 
the 5’ splice site. In higher eukaryotes, the 3’ splice site and adjacent Py tract are identified 
through interactions with U2 snRNP auxiliary factor (U2AF) composed of a large subunit of 
65 kDa (U2AF65) and a small subunit of 35 kDa (U2AF35). U2AF65 is an essential splicing 
factor that binds to the polypyrimidine tract and contacts also the branch point (Guth et al., 
2001; Kent et al., 2003), while U2AF35 binds to the conserved AG dinucleotide at the 3’ 
splice site and is dispensable for splicing of some introns that contain “strong” 
polypyrimidine tracts (Pacheco et al., 2006; Pacheco et al., 2004). The branch point is also 
specifically recognised by the splicing factor 1 / mammalian branch point binding protein 
(SF1/mBBP), in a cooperative binding with U2AF65 (Selenko et al., 2003). These ATP 
independent events lead to the formation of an E (early) complex that commits the pre-mRNA 
to the splicing pathway. These interactions help the recruitment of the U2 snRNP to the 
branch point in an ATP dependent manner (Sanford and Caceres, 2004). U2 snRNA base 
pairs with the branch point sequences generating the pre-spliceosome or A complex. Several 
proteins of the SR family are thought to mediate interactions between adjacent 5’ and 3’ 
splice sites, both across the intron and over the exon helping to determine the correct splice 
site selection and to stabilize the A complex (Hertel and Graveley, 2005; Shen and Green, 
2004).  This complex recruits the pre-formed U4/U6.U5 tri-snRNP to form the mature 
spliceosome or B complex. The U4 snRNA does not directly interact with the pre-mRNA but 
plays an essential role in bringing U5 and U6 into the spliceosome. At this step, the U1 base 
pairing interaction with the 5’ splice site is replaced by a similar interaction involving the U6 
snRNA, while U5 binds to sequences in the 3’ exon, thus bringing the two exons closer 
together. Extensive conformational changes promote the dissociation of U1 and U4 from the 
complex and the spliceosome is activated (B* complex) and capable of catalyzing the first 
splicing reaction whereby the branch point adenosine is connected to the 5’ end of the intron, 
which is cleaved from the upstream exon. The intron is now in a lariat configuration and the C 
complex is formed. More conformational changes are required for the second trans-
esterification reaction to occur, in which the 3’ end of the upstream exon is joined with the 5’ 
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end of the downstream exon, cleaving the intron from the 3’ end splice site. After this final 
step, the spliced mRNA is released from the post-spliceosomal complex formed by the lariat 
intron and the snRNPs, which must disassemble and recycle for another round of splicing 
(Figure 3B) (reviewed by Hastings and Krainer, 2001; Jurica and Moore, 2003). Assembly of 
the U12-dependent spliceosome is similar to that of the U2-dependent, with the U11, U12 and 
U4atac/U6atac being functionally similar to the U1, U2 and U4/U6. The major difference 
occurs at the earliest assembly step in which the U11 and U12 snRNPs form a highly stable 
di-snRNP that binds cooperatively to the 5’ splice site and branch point, which is equivalent 
to the A complex of the U2-dependent spliceosome (reviewed by Will and Luhrmann, 2005). 
 While many introns are constitutively excised during splicing, other introns and exons 
can either be included or excluded from the mature mRNA, in different combinations in a 
process called alternative pre-mRNA splicing (for reviews see Blencowe, 2006; Matlin et al., 
2005). By this process a single pre-mRNA yields different mRNAs leading to the production 
of different proteins creating proteome diversity. It has been estimated that more than 50% of 
all human genes are, at some stage, expressed by alternative splicing (see Modrek and Lee, 
2002).  
 
3’ end processing 
The 3’ end processing of the transcripts consists in a two-step reaction involving site-
specific endonucleolitic cleavage of the pre-mRNA and synthesis, at the newly generated 3’ 
product, of a poly(A) tail of 70–90 adenosine residues in yeast (S. cerevisiae) and 200–250 
adenosine residues in higher eukaryotes. The two steps of the reaction (cleavage and 
polyadenylation) are considered to be tightly coupled, as cleaved 3’ ends that were not 
polyadenylated have not been observed in vivo. With the exception of replication-dependent 
histone transcripts (in higher eukaryotes), that possess a stem-loop structure at their 3’ end, all 
protein encoding mRNAs contain a poly(A) tail (see Proudfoot et al., 2002; Zhao et al., 1999). 
The poly(A) tail is an important determinant of mRNA metabolism and function, largely 
through the action of cellular poly(A) tail-binding proteins (PABPs) (for a review see Mangus 
et al., 2003). PABPs have a minimal binding site of 11–12 adenosines and, as a consequence, 
a single poly(A) tail is bound by multiple PABP molecules (Mangus et al., 2003). While 
higher eukaryotes have multiple PABPs, including several cytoplasmic forms (PABPC) and 
one nuclear (PABPN1), yeast cells have a predominantly cytoplasmic poly(A)-binding 
protein (Pab1p) although cell fractionation indicates that some Pab1p is also nuclear (Zhao et 
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al., 1999). Orthologs of PABPN1 were not identified in yeast. However, recent studies 
indicate that the yeast heterogeneous nuclear ribonucleoprotein (hnRNP) Nab2p is a strong 
candidate for a yeast equivalent of PABPN1 function, at least for a subset of mRNAs (Hector 
et al., 2002).  
In mammals, three elements define the core polyadenylation signal: the highly 
conserved hexanucleotide AAUAAA found 10 to 30 nucleotides upstream of the cleavage 
site; a less conserved U-rich or GU-rich element located downstream of the cleavage site and 
the cleavage site itself, which occurs predominantly after a CA dinucleotide and becomes the 
point of poly(A) addition being generally referred as the poly(A) site (Figure 4A) (see 
Gilmartin, 2005).  
The cleavage and polyadenylation machinery has been extensively studied in vitro. 
Because in vitro it is possible to uncouple the cleavage and polyadenylation reactions, most of 
the factors involved in each reaction have been identified. In mammals, these include: the 
cleavage-polyadenylation-specificity factor (CPSF), required for both cleavage and 
polyadenylation; the cleavage stimulatory factor (CstF), necessary only for cleavage; two 
cleavage factors (CF Im and CF IIm - the subscript m is used to differentiate the mammalian 
factor from the yeast one), required only for cleavage; the poly(A) polymerase (PAP), whose 
major role is in polyadenylation but is also required for cleavage and PABPN1 required for 
polyadenylation. In addition, the CTD of the largest subunit of RNA polymerase II (RNA Pol 
II LS) was also found to be required for efficient pre-mRNA cleavage (Figure 4B) (reviewed 
by Proudfoot, 2004; Zhao et al., 1999).  
CPSF is a large protein complex containing subunits of 160, 100, 70 and 30 kDa 
(CPSF-160, CPSF- 100, CPSF- 70 and CPSF- 30, respectively) and has been shown to 
recognise the AAUAAA signal through CPSF-160. CstF consists of three polypeptides of 77, 
64 and 50 kDa and binds to the GU – rich sequence downstream to the site of cleavage 
through its 64 kDa subunit. CF Im consists of three subunits that are able to interact directly 
with a pre-mRNA substrate. CF IIm, only recently partially purified, can be subdivided into 
two fractions of which only fraction CF IIAm appears to be essential for the cleavage reaction. 
PAP is present in at least two enzymatically active forms obtained by alternative splicing, 
PAP I (77 kDa) and PAP II (82 kDa), differing only at the carboxyl terminus. CPSF and PAP 
are sufficient for poly(A) addition to a pre-cleaved RNA substrate. However, to achieve rapid 
elongation and to control the length of the poly(A) tail PABPN1 is essential (Proudfoot and 
O'Sullivan, 2002; Zhao et al., 1999). PABPN1 is a 33 kDa protein that binds specifically to 
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the poly(A) tail via two RNA binding domains (Kuhn et al., 2003; Tavanez et al., 2005), 
forming spherical protein-RNA complexes with a diameter of 21 nm (Keller et al., 2000).  
 
 
 
Figure 4 - Mammalian pre-mRNA 3’ end processing. (A) Schematic representation of the 
mammalian poly(A) site with conserved sequence elements and relative distances between 
them. Adapted from (Gilmartin, 2005). (B) Simplified view of the cleavage and 
polyadenylation reactions. Direct cleavage of the mRNA requires CPSF, CstF, two additional 
cleavage factors (CF I and CF II), PAP and the phosphorylated CTD (pCTD) of RNA 
Polymerase II. PAP together with CPSF, directs poly(A) addition. PABPN1 (PAB) binds the 
growing poly(A) tail, greatly enhancing the efficiency of polyadenylation and forming 21 nm 
spherical particles (see text for details). Adapted from (Proudfoot et al., 2002). 
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In mammals the following model has been proposed for the 3’ end processing reaction 
(Figure 4B). The initial step is probably the recognition of the signals on the pre-mRNA by 
CPSF and CstF in a process assisted by CF Im. It is not known when the precise cleavage site 
is chosen, but the CPSF-CstF interaction defines the region in which it must lie. The 
formation of a cleavage-competent complex requires the additional recruitment of CF IIm and 
PAP and there is no indication of a reorganisation of the complex before catalysis, as occurs 
during the splicing reaction (Zhao et al., 1999). The nature of the endoribonuclease activity 
that is responsible for the cleavage reaction has remained elusive for a long time but recently 
two studies provided evidence that it might be the CPSF-73 subunit (Callebaut et al., 2002; 
Ryan et al., 2004). The CTD of RNA Pol II LS enhances the cleavage reaction, likely via 
interactions with CPSF and CstF (Hirose and Manley, 1998; McCracken et al., 1997b). The 
cleavage reaction is followed by polyadenylation. In this step PAP is recruited to the 
AAUAAA-containing substrate thought its interaction with CPSF and slow polymerization 
starts. After a binding site for PABPN1 has been created, the elongation proceeds at a faster 
speed until the poly(A) tail reaches approximately 200 adenosine residues. PABPN1 forms a 
spherical protein-RNA complexe with a 21 nm diameter (Keller et al., 2000), whose function 
remains unclear, although there has been some speculation that it might be related with 
measuring the length of the poly(A) tail (Kuhn and Wahle, 2004). When the Poly(A) tail 
reaches the right size processive elongation switches to a slow mode again and termination of 
polymerization is probably coupled with the release of CPSF and PAP from the finished 
product, although the mechanism is still not understood (see Zhao et al., 1999).  
In S. cerevisiae the cis elements for 3’ end formation are poorly defined, though three 
redundant and degenerate sequences are generally identifiable: the polyadenylation-cleavage 
site (PyAn), an “efficiency element” (UAUAUA, or repeats thereof) located a variable number 
of nucleotides 5’ to the poly(A) site, and a “positioning element” (AAUAAA, AAAAAA, and 
related sequences) located approximately 20 nucleotides 5’ to the poly(A) site (reviewed by 
Zhao et al., 1999). The 3’ end processing machinery in yeast includes the cleavage and 
polyadenylation factor IA (CFIA), cleavage and polyadenylation factor IB (CFIB), cleavage 
and polyadenylation factor (CPF), poly(A) polymerase (Pap1p), poly(A)-specific nuclease 
(PAN) and the poly(A)-binding proteins Pab1p and Nab2p (Proudfoot and O'Sullivan, 2002; 
Zhao et al., 1999). Since many of the yeast factors have only recently been characterised, less 
is known about how they interact with the RNA precursor and with each other. CFIA contains 
subunits homologous to those of mammalian CstF and CF IIm while CPF contains homologs 
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of CPSF as well as other mammalian cleavage and polyadenylation factors. During 3’ end 
processing, multiple Pab1 proteins are loaded onto the poly(A) tail and are exported as part of 
the mensenger ribonucleoprotein particle (mRNP). One nuclear function of Pab1p is to 
modulate the overall length of the poly(A) tail, which is initially synthesized at a length 
greater than is found on newly exported mRNA. The multisubunit complex PAN is recruited 
by Pab1p and is thought to trim the poly(A) tail to the appropriate length (Dunn et al., 2005). 
The nuclear poly(A)-binding protein Nab2p is also required for poly(A) tail length control. 
Loss of NAB2 expression leads to hyperadenylation of the transcripts and although cells are 
viable in the absence of NAB2 expression when PAB1 is overexpressed, Pab1p fails to 
resolve the hyperadenylation defect indicating that Nab2p is essential for poly(A) tail length 
control in vivo (Hector et al., 2002). 
 
Editing 
In addition to capping, splicing and 3’ end formation, another RNA processing 
reaction that affects the pre-mRNA is editing. This co- or post-transcriptional RNA 
processing reaction changes the nucleotide sequence of the RNA substrate by insertion or 
deletion of nucleotides or by the substitution of bases by modification (for reviews see Gott 
and Emeson, 2000; Schaub and Keller, 2002). The major type of RNA editing in the nucleus 
of higher eukaryotes is base modification and the best characterised reactions are hydrolytic 
deaminations with conversion of cytidine (C) to uridine (U) and adenosine (A) to inosine (I). 
The conversion of C to U in pre-mRNA is catalysed by cytidine deaminase acting on RNA 
(CDAR) complexes and conversion of A to I is catalysed by adenosine deaminase that act on 
RNA (ADAR) polipeptides (reviewed by Gerber and Keller, 2001). In mammals, two active 
ADAR enzymes with different substrate specificities have been characterised, ADAR1 and 
ADAR2 (Hartner et al., 2004; Higuchi et al., 2000). The first RNA-editing reaction 
discovered in mammals was the tissue-specific modification of apolipoprotein B mRNA 
(Powell et al., 1987). In this substrate, deamination of C to U changes a glutamine codon 
(CAA) to a stop codon (UAA), resulting in the translation of a shorter protein termed apoB48. 
In humans, such editing is restricted to the small intestine, and the unedited full-length protein 
(apoB100) is synthesized in the liver (see Gerber and Keller, 2001). This is one of the few 
examples in mammals of C to U changes in mRNA resulting from RNA editing. The A to I 
conversion which is read by the translation machinery as a G, is the most frequent editing 
reaction in higher eukaryots and has been described in different tissues but most of the known 
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targets are pre-mRNAs expressed in the central nervous system (see Schaub and Keller, 
2002). Well studied editing substrates in the brain include subunits of the glutamate ion 
channel family or the serotonin 5-HT2C receptor (Gerber and Keller, 2001). ADAR editing 
occurs with low selectivity on completely double-stranded RNA (dsRNA) or selectively on 
structured RNA, interrupted by bulges of loops (Bass, 2002). Because dsRNA structure can 
be formed by pairing of intronic and exonic sequences it was hypothesised that the speed of 
splicing could regulate the extent of editing. However, it was shown that at least for the 
glutamate receptor subunit B pre-mRNA the absence of editing prevents splicing of an intron 
adjacent to an editing site, which showed that editing can regulate splicing (Higuchi et al., 
2000). It was also shown recently that the CTD of RNA pol II is required for efficient co-
transcriptional editing of ADAR2 pre-mRNA (Laurencikiene et al., 2006) and that the CTD 
and ADAR2 function together to enforce the order of events that allows editing to precede 
splicing in the glutamate receptor subunit B pre-mRNA (Ryman et al., 2007). 
So far only a few pre-mRNA substrates of editing have been identified, nevertheless, 
the impact of pre-mRNA editing in the regulation of gene expression can be significant. 
Editing can affect other pre-mRNA processing reactions such as splicing, alter the specificity 
of a codon, create new start and stop codons or even new open reading frames generating 
protein isoforms with different functions that could not be predicted from the corresponding 
genomic sequence (for reviews see Gott and Emeson, 2000; Schaub and Keller, 2002). 
 
2.3 Nuclear export and translation 
 
Cellular mRNA molecules produced in the nucleus must be exported to the cytoplasm 
to allow their translation into proteins. Many of the proteins synthesized in the cytoplasm 
have a role in nuclear metabolism. This division requires nucleo-cytoplasmic transport 
pathways that can rapidly and specifically transport the molecules from their site of synthesis 
to their site of use. Nuclear export of mRNA, like the exchange of all macromolecules 
between the nucleus and the cytoplasm, occurs through large structures embedded in the 
nuclear envelope called nuclear pore complexes (NPCs) (see Allen et al., 2000; Ryan and 
Wente, 2000). In higher eukaryotes, NPCs are composed of approximately 50-80 distinct 
proteins, collectively referred to as nucleoporins (Nups), which assemble into a 
supramolecular structure forming an aqueous channel across the nuclear envelope. A subset of 
these nucleoporins contains characteristic domains with multiple repeats of short peptide 
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sequences ending in the amino acids phenylalanine and glycine (FG). These FG repeats are 
believed to function as transient docking sites for nucleo-cytoplasmic transport factors. Other 
features of the NPC include the nuclear basket, nuclear and cytoplasmic rings, short 
cytoplasmic fibrils, and a central spoke complex (reviewed by Vasu and Forbes, 2001). Small 
molecules (≤ 40 kDa) can cross the NPC by passive diffusion, but most of the molecules that 
move between the nucleus and the cytoplasm are actively transported. Soluble proteins known 
as transport receptors are required for passage of the molecules to be transported (cargos) 
through the NPC by mediating interactions with the nucleoporins. The bulk of cellular nucleo-
cytoplasmic transport is mediated by factors that belong to a single family of nuclear transport 
receptors termed “karyopherins” or importins/exportins. Different members of this protein 
family bind to distinct cargo molecules, or to adapter proteins that in turn bind cargo, and also 
share the ability to interact with specific nucleoporins. For example, U snRNA and tRNA 
require exportin 1/CRM1 and exportin-t, respectively. A karyopherin family member that 
functions in general mRNA export has not been identified (reviewed by Cullen, 2003).  
Nuclear mRNA molecules exist as large RNA-protein complexes, thus the transport 
substrate recognised by the mRNA export machinery is the messenger ribonucleoprotein 
particle (mRNP). Despite intensive investigation, the molecular mechanisms of mRNA export 
are not completely clear yet. A general feature of mRNA export is that it is an active, 
receptor-mediated process. The mRNA export receptors are thought to recognise and bind to 
the mRNP-export cargoes either directly or indirectly (via adaptor proteins) and facilitate their 
translocation across the central channel of the NPC. On the cytoplasmic side of the NPC, the 
exported mRNP is released and the receptor returns to the nucleoplasm, without the cargo, to 
initiate additional rounds of export. Recent studies in yeast and in higher eukaryotes have led 
to the elucidation of an evolutionarily conserved pathway for the export of bulk mRNP to the 
cytoplasm. The best candidate for an mRNP export receptor in a heterodimer composed of a 
large subunit, TAP or NXF1, and a small cofactor called p15 or NXT1. In yeast cells the TAP 
ortholog is Mex67p and the small cofactor is Mtr2p. NXF1 belongs to a conserved family of 
nuclear export factor proteins (NXF) that are distinct from the karyopherin family of transport 
receptors but associate with NPC and have the ability to shuttle. NXT1 is conserved in 
metazoan but does not show any obvious sequence similarity to Mtr2, being nevertheless 
functionally analogous. Mtr2p is required for the binding of Mex67p to NPCs and NXT1 is 
also essential for NXF1 association with nucleoporins and recruitment to NPCs in vivo 
(reviewed by Erkmann and Kutay, 2004; Stewart, 2007; Stutz and Izaurralde, 2003). 
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Mex67p was first detected in yeast via a synthetic lethal screen with Nup85p, a 
nucleoporin involved in mRNA export. Mutants of the MEX67 gene accumulate poly(A)+ 
RNA in the nucleus (Santos-Rosa et al., 1998; Segref et al., 1997). Evidence that NXF1 
(originally called TAP) is involved in mRNA export in metazoans was first provided by 
studies of a host factor that facilitates export of type D retroviral RNAs by binding directly to 
the constitutive transport element (CTE) of these RNAs (Bray et al., 1994; Gruter et al., 
1998). Subsequent work showed that NXF1-NXT1 (or TAP-p15) stimulates export of cellular 
mRNAs, confirming its role in mRNA export (Braun et al., 2001; Guzik et al., 2001; Katahira 
et al., 1999).  
Although NXF1 and Mex67p exhibit a general RNA binding affinity in vitro, their 
association with nuclear mRNAs is thought to be mediated by protein-protein interactions 
(see Stutz and Izaurralde, 2003). Proteins that might act as adapters between mRNAs and the 
heterodimer have been identified through genetic and biochemical approaches. In S. 
cerevisiae, Yra1p was identified as an mRNA export adapter for Mex67p. YRA1 gene encodes 
an RNA binding protein, which causes nuclear accumulation of poly(A)+ mRNA when it is 
deleted (Strasser and Hurt, 2000; Stutz et al., 2000; Zenklusen et al., 2001). Proteins 
homologous to Yra1p have been identified in human, mouse, C. elegans, Xenopus and 
Drosophila, and belong to an evolutionary conserved protein family called RNA export factor 
binding proteins or REFs. These proteins bind directly to both RNA and NXF1 (or Mex67p) 
(see Erkmann and Kutay, 2004). In Xenopus oocytes, antibodies specific to REFs that prevent 
their interaction with RNA reduce the export rate of mRNA (Rodrigues et al., 2001) and 
microinjection of recombinant REF1 stimulates the export of mRNA that was inefficiently 
exported (Rodrigues et al., 2001; Zhou et al., 2000). Nevertheless, studies in Drosophila cells 
indicate that REF might contribute to but is not essential for mRNA export (Gatfield and 
Izaurralde, 2002). REFs are also dispensable for mRNA export in C. elegans (Longman et al., 
2003). This raises the possibility that other adaptor protein(s) can bridge the interaction 
between NXF1-NXT1 (or TAP-p15) and cellular mRNAs in metazoan. Exactly how NXF1-
NXT1 and the adaptor proteins are recruited to mRNAs remains uncertain but there is 
increasing evidence that it may be coupled to the synthesis and/or post-transcriptional 
processing of mRNAs (discussed in detail in section 3). 
Once in the cytoplasm, mRNA molecules carry the genetic information to the protein-
synthesizing machinery, where it is used to define the amino acid sequence of the 
polypeptides, and ultimately the structure and function of proteins. However, the translation 
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of mRNA is only the first step in the formation of a protein. The polypeptide chain is in most 
cases subjected to post-translational modifications and must fold into the appropriate three-
dimensional conformation to achieve its active form (see Hausman, 2004). Translation takes 
place on the ribosome, a large ribonucleoprotein particle that consists of two subunits, 
designated 40S and 60S in eukaryotes, and involves also a large number of additional protein 
factors. Translation of mammalian mRNAs occurs by a scanning mechanism, in which the 
40S ribosomal subunit, primed for initiation by the binding of several initiation factors, is 
loaded on the mRNA immediately downstream of the 5’ cap and scans the mRNA in the 5’ to 
3’ direction. Upon recognition of the initiation codon (the first AUG triplet) via base pairing 
with the Met-tRNA(i) anticodon, scanning ceases and the 60S subunit joins completing the 
initiation process (reviewed by Jackson, 2005). 
It is now accepted that some proteins recruited to transcripts during their biogenesis in 
the nucleus, accompany the mRNAs to the cytoplasm and may influence their fate and 
ultimately their translation (see Dreyfuss et al., 2002; Kuersten and Goodwin, 2005). 
Furthermore, newly exported mRNPs have a protein composition distinct from mRNPs that 
have undergone the initial round of translation. For example, during this initial round the 
nuclear cap-binding complex (CBC), a dimmer composed of CBP20 and CBP80, is replaced 
by the cytoplasmic translation initiation factor, eIF-4F. The interaction between the cap-
binding subunit of eIF-4F (eIF-4E) and the poly(A)-binding protein (PABP) will circularize 
the mRNP resulting in a translationally competent complex. The “closed loop” conformation 
of the mRNP may promote translational competence by enabling the recycling of ribosomes 
from the 3’ to the 5’ end of the mRNA (see Mitchell and Tollervey, 2001). The first round of 
translation has also been proposed to constitute a final quality control step in mRNA 
biogenesis allowing the identification of messages that contain premature termination codons 
(Kuersten and Goodwin, 2005). Recently it was proposed that this pioneer round of 
translation occurs when the mRNA is still in the nucleus challenging the prevailing view that 
translation is limited to cytoplasmic ribosomes (Iborra et al., 2004; Iborra et al., 2001). 
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3. Coupling between steps of gene expression 
 
Studies over the past few years have revealed that virtually all of the steps in gene 
expression are extensively coupled to one another (see for example Bentley, 1999; Hirose and 
Manley, 2000; Kornblihtt et al., 2004; Proudfoot et al., 2002; Zorio and Bentley, 2004). 
Recent findings revealed that a highly interconnected system encompassing gene 
transcription, pre-mRNA processing, mRNA export and cytoplasmic mRNA translation and 
turnover operate in eukaryotic cells (reviewed by Maniatis and Reed, 2002). The major pre-
mRNA processing steps – 5’ capping, splicing and 3’ end processing – are coupled to 
transcription (reviewed by Proudfoot et al., 2002; Zorio and Bentley, 2004). This functional 
coupling is achieved by physical contacts between the protein machines that perform 
transcription and pre-mRNA processing. The link between these protein machines is the 
carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (RNA Pol II 
LS). The assembly of different protein complexes on the CTD can function by increasing the 
local concentration of processing factors, by coupling the rate of transcription with the 
assembly of specific RNA-protein complexes, and by allosterically activating and inhibiting 
the same complexes (Bentley, 2005).  
The first evidence that the CTD is important for pre-mRNA processing was provided 
by Bentley and colleagues (McCracken et al., 1997a; McCracken et al., 1997b), who 
demonstrated that deletion of the CTD prevents efficient capping, splicing and 3′ end 
cleavage in vivo. Coupling among different pre-mRNA processing steps seems also to be 
critical for gene expression (reviewed by Maniatis and Reed, 2002; Proudfoot et al., 2002). 
The existence of interactions between capping and splicing, as well as interactions between 
splicing and 3’ end processing in conjunction with the recruitment of the splicing machinery 
to internal exons in the pre-mRNA, play an important role in ensuring that the correct splice 
sites are recognised and engaged in the splicing reaction and that the transcripts are correctly 
capped and polyadenylated. It has long been suspected that RNA processing and export must 
be in some way connected to ensure that only the final mRNA product leaves the nucleus. 
Recent progress in identifying soluble factors important to mRNA trafficking is beginning to 
reveal the molecular basis for such a functional coupling (for reviews see Cullen, 2003; Reed, 
2003; Reed and Cheng, 2005). 
All the interactions described above represent a quality control mechanism to ensure 
that no individual processing reaction is omitted and that they are all timely, accurate and 
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efficient with the ultimate goal of producing a mature mRNA molecule (Maniatis and Reed, 
2002).  
 
3.1 Connecting transcription with pre-mRNA processing 
 
The connector: the carboxyl-terminal domain of RNA polymerase II  
The CTD of RNA Pol II LS contains multiple potential phosphorylation sites within 
its heptapeptide consensus sequence and undergoes dynamic changes in phosphorylation 
during the transcription cycle, which plays a significant role in coordinating its multiple 
activities (Meinhart et al., 2005; Phatnani and Greenleaf, 2006). The CTD is mostly 
hypophosphorylated (form IIa) when recruited to the promoter and becomes 
hyperphosphorylated (form IIo) during transcription elongation. When transcription initiates, 
the CTD is first phosphorylated on Ser5 by CDK7, the TFIIH-associated kinase and later on 
the Ser2 residues by CDK9, the kinase associated to the positive transcription elongation 
factor b (P-TEFb) (reviewed by Palancade and Bensaude, 2003). It was recently shown that 
transcribing RNA Pol II is also phosphorylated at Ser7 (Chapman et al., 2007). This 
phosphorylation is required for expression of snRNA but not protein-coding genes (Egloff et 
al., 2007). Chromatin immunoprecipitation (ChIP) assays, using antibodies directed to the 
hypo- and the hyperphosphorylated forms of the CTD, have helped to map the evolution of 
CTD phosphorylation along a transcribed gene in vivo. In S. cerevisiae, Ser5 phosphorylation 
is detected primarily at promoter regions dependent on TFIIH. In contrast, Ser2 
phosphorylation is seen only in coding regions (Komarnitsky et al., 2000). In the mammalian 
genes studied, RNA Pol II is more concentrated in the promoter-proximal regions than in the 
interior regions and different phosphorylation forms of the CTD are also associated with 
distinct regions. Ser5 phosphorylation is concentrated near the promoter, while Ser2 
phosphorylation is observed throughout the gene (Cheng and Sharp, 2003). 
How exactly the changes in CTD phosphorylation are regulated is not well 
understood. It has been shown that CTD conformational changes induced by the peptidyl-
prolyl isomerase Pin1 affect both CTD kinase and phosphatase activities by remodelling their 
substrate (Xu et al., 2003). Although Pin1 plays a significant role in regulating RNA Pol II 
CTD structure and function is still not known if this enzyme affects the recruitment of mRNA 
processing factors. The CTD is also O-glycosylated in serine residues in a manner that is 
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mutually exclusive with serine phosphorylation, suggesting that there could be cross-talk 
between these two modifications (Comer and Hart, 2001). 
The CTD interacts with many factors throughout the transcription cycle, including the 
Mediator complex that regulates transcription initiation, the capping enzymes and 
polyadenylation factors (see Figure 2B). Rather than carrying all these factors throughout the 
transcription cycle, the CTD interacts dynamically with each factor at the appropriate time. 
But how can such a simple sequence interact with so many targets in such a coordinate way? 
One hypothesis is that there is a CTD “code” that specifies the position of the RNA Pol II in 
the transcription cycle (see Buratowski, 2003). A lot of information can be encoded in the 
CTD simply by regulating the timing of phosphorylation events during the transcription cycle. 
If we consider all the possible configurations resulting from proline isomer patterns, the level 
of complexity of the “code” increases considerably. The CTD “code” could consist in a series 
of different phosphorylation and conformational changes that generate configurations specific 
for binding of particular factors. The complexity of the CTD “code” could be even higher if 
we consider all the other covalent modifications that have been reported for the CTD 
(including ubiquitination, glycosylation and phosphorylation of other residues within the 
repeat) and the nonconsensus repeats found in most organisms (Buratowski, 2003).  
 
Transcription and capping  
Capping is the best described example of a pre-mRNA processing reaction coupled to 
transcription. Evidence has accumulated over the last decade, showing that capping is 
facilitated by an association of the capping enzymes with the CTD (reviewed by Bentley, 
2005; Howe, 2002; Zorio and Bentley, 2004). In the yeast S. cerevisiae, the RNA 
guanylyltransferase (Ceg1) associates in vitro with the phosphorylated form of the CTD (Cho 
et al., 1997) but it cannot form the covalent GMP intermediate unless the RNA triphosphatase 
subunit (Cet1) is also present (Cho et al., 1998). Therefore, the yeast Ceg1 is regulated by 
allosteric interactions with both the Cet1 and the CTD (Cho et al., 1998), which may reflect 
the need to coordinate both activities. ChIP experiments in S. cerevisiae demonstrated that 
Cet1 and Ceg1 crosslink to promoter regions of transcribing genes and the CTD kinase kin28 
(CDK 7 in mammals) is required for binding (Komarnitsky et al., 2000; Rodriguez et al., 
2000; Schroeder et al., 2000). Both the extent of CTD phosphorylation at Ser5 of the heptad 
repeat and the binding of capping enzymes decreased as the polymerase moved from the 5' to 
the 3’ end of genes. The CTD phosphatase, Fcp1, is required for dissociation of capping 
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enzymes from the elongation complex (Schroeder et al., 2000). The yeast methyltransferase 
(Abd1) crosslinked with promoter regions and coding regions further downstream 
(Komarnitsky et al., 2000; Schroeder et al., 2000). In mammals, the capping enzyme is able to 
directly interact with the phosphorylated CTD through the guanylyltransferase domain (Fong 
and Bentley, 2001; Ho et al., 1998; McCracken et al., 1997a) and the human 
methyltransferase binds to the complex of human capping enzyme and phosphorylated CTD 
(Pillutla et al., 1998). The human capping enzyme can associate with CTD peptides that are 
phosphorylated on either Ser2 or Ser5; however only the Ser5 phosphorylated CTD peptides 
stimulate the capping reaction (Ho and Shuman, 1999). Binding of the capping enzyme to the 
CTD not only localises the enzyme but also allosterically regulates it, reducing the Km of the 
mammalian guanylyltransferase for GTP (Ho and Shuman, 1999).  
There is now convincing evidence that the link between transcription and capping 
works both ways. Not only the capping reactions are influenced by the transcription 
machinery, as mentioned above, but the capping enzymes may also have an important role in 
regulating early steps in transcription (reviewed by Bentley, 2005). It is believed that during 
the formation of the transcription initiation complex, or soon after initiation, DRB sensitivity-
inducing factor (DSIF) is recruited to the transcription complex. Additionally, after initiation 
of transcription, the negative elongation factor (NELF) is recruited through interaction with 
DSIF. This results in the arrest of the transcription complex before it enters into productive 
elongation. DSIF/NELF mediated arrest is then overcome by the positive transcription 
elongating factor, P-TEFb, and the associated protein kinase, CDK9, which phosphorylates 
both the CTD at Ser2 and Spt5, the larger subunit of DSIF (see Figure 2B) (reviewed by 
Orphanides and Reinberg, 2002). In mammals and in the fission yeast Schizosaccharomyces 
pombe (S. Pombe), Spt5 interacts directly with the RNA triphosphatase and 
guanylyltransferase and stimulates RNA guanylylation (Pei and Shuman, 2002; Wen and 
Shatkin, 1999). The S. cerevisiae Abd1, stabilizes RNA Pol II on some promoters and both 
Abd1 and Ceg1 stimulate early elongation (Kim et al., 2004a; Schroeder et al., 2004), whereas 
Cet1 inhibits re-initiation (Myers et al., 2002). Stimulation of transcription by Abd1 occurs in 
a methylation-defective mutant and is therefore independent of capping itself (Schroeder et 
al., 2004). The human capping enzyme stimulates promoter escape by countering the negative 
elongation factor NELF, and capping enzyme recruitment is enhanced by direct binding to the 
elongation factor Spt5 (Mandal et al., 2004). In summary, capping enzymes have a previously 
unsuspected ability to manipulate early steps in transcription. In this way they may operate a 
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checkpoint to ensure timely capping of the nascent pre-mRNA before commitment to 
processive elongation of the transcript, ensuring that only properly capped RNA molecules 
are extended. 
 
Transcription and splicing  
The first evidence for a functional connection between transcription and splicing came 
from studies back in the 80’s, showing that when transcription of an RNA Pol II gene was 
directed by an RNA Pol I or III promoter, splicing was inhibited (Sisodia et al., 1987; Smale 
and Tjian, 1985). An explanation for this early observation came many years later with 
several studies pointing to the CTD of RNA Pol II as the landing platform that allows the 
assembly of the processing machinery (reviewed by Hirose and Manley, 2000). Since the 
CTD domain is exclusive of RNA Pol II, the processing machinery could not be efficiently 
recruited to the chimaeric genes and splicing was impaired.  
The idea that the CTD may function as a landing platform for the assembly of the 
splicing machinery was first proposed in 1993 by Greenleaf (Greenleaf, 1993). He presented a 
speculative model for co-transcriptional splice site selection in the pre-mRNA involving 
interactions between the negatively charged hyperphosphorylated CTD of RNA Pol II and the 
positively charged splicing factors with an RS-domain. In the following years several studies 
reported physical and functional interactions between the CTD and the splicing machinery 
(reviewed by Hirose and Manley, 2000). Splicing factors were shown to immunoprecipitate 
with the hyperphosphorylated RNA Pol II (RNA Pol IIO), but not with the 
hypophosphorylated polymerase (RNA Pol IIA), even in the absence of pre-mRNA (Kim et 
al., 1997; Mortillaro et al., 1996). Antibodies directed against the CTD and CTD peptides 
have been shown to inhibit splicing in vitro (Chabot et al., 1995; Yuryev and Corden, 1996) 
and the overexpression of phosphorylated CTD peptides inhibit splicing in cultured 
mammalian cells (Du and Warren, 1997). Evidence for a direct role for RNA Pol II in the 
splicing reaction independently of transcription came from in vitro reconstituted splicing 
assays in which RNA Pol II influences very early steps in the assembly of the spliceosome. 
This assays showed also that the phosphorylation status of the CTD has a dramatic effect in 
the splicing reaction, with RNA Pol IIO form strongly activating splicing and the RNA Pol 
IIA inhibiting the reaction (Hirose et al., 1999). Furthermore, experiments in which plasmid 
templates or pre-synthesized full-length pre-mRNAs were microinjected into Xenopus oocytes 
indicated that both co-and post-transcriptional splicing can occur in vivo, but only co-
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transcriptional splicing is dependent on CTD phosphorylation (Bird et al., 2004). New 
insights into the mechanism by which the CTD functions in splicing come from recent in vitro 
experiments using a chimeric protein in which the CTD of RNA Pol II was fused to the C-
terminus of the splicing factor SF2/ASF (ASF–CTD). Compared to SF2/ASF alone, ASF–
CTD increased the reaction rate during the early stages of splicing but only when the CTD 
moiety was phosphorylated and the SF2/ASF moiety was bound to RNA (Millhouse and 
Manley, 2005).  
A number of in vivo experiments gave valuable clues for a functional role of the CTD 
in coupling transcription to splicing. In a pioneer study, Bentley and co-worker’s showed that 
RNA molecules transcribed in transient transfection assays by RNA Pol II with a truncated 
CTD containing only 5 repeats are less efficiently spliced than RNA molecules made by an 
RNA Pol II with a full-length CTD (McCracken et al., 1997b). This same CTD truncation was 
also shown to prevent the targeting of the splicing machinery to a transcription site in 
mammalian cells, suggesting a role for the CTD in the intranuclear targeting of splicing 
factors to transcription sites in vivo (Misteli and Spector, 1999). An analysis using RNA Pol II 
with different regions of the CTD truncated showed that different CTD regions can serve 
distinct functions in pre-mRNA processing, with the CTD carboxyl-terminus (including 
heptads 27-52) supporting capping, splicing and 3’ end processing whereas the amino 
terminus (heptad repeats 1-15 or 1-25) supports only capping (Fong and Bentley, 2001). 
Further dissection of the CTD sequence showed that the C-terminal 10 amino acid motif that 
follows the 52 heptad repeats is also essential for high level transcription, splicing and 
poly(A) site cleavage (Fong et al., 2003). Efficient mRNA synthesis from a transiently 
transfected reporter gene requires between 16 and 25 heptad repeats from either the N- or C-
terminal half of the CTD plus the C-terminal 10 amino acid motif (Fong et al., 2003). 
The finding that promoter structure can influence alternative splice site selection 
extended the concept of a physical and functional coupling between transcription and splicing, 
suggesting additional levels of interplay (Cramer et al., 1999; Cramer et al., 1997). Using a 
series of human α-globin/fibronectin (FN) minigenes that include the alternatively spliced 
extra domain I (EDI) exon of FN and differing in the promoter driving their expression, it was 
demonstrated that the extent of EDI splicing is dependent on the promoter structure from 
which the transcript originated, independently of the promoter strength (Cramer et al., 1997). 
Furthermore, it was also shown that the promoter structure affected the responsiveness of this 
alternative splicing to the activation by the SR proteins SF2/ASF and 9G8 (Cramer et al., 
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1999). Since the effect of these splicing factors requires the presence of an intact EDI exonic 
splicing enhancer (ESE) in order to stimulate EDI inclusion, it was suggested that the 
transcription machinery modulates the recruitment of specific SR proteins to exonic splicing 
enhancers (Cramer et al., 1999). Promoter control of alternative splicing has been extended to 
the cystic fibrosis transmembrane regulator (CD44), the calcitonin-gene-related peptide genes 
and the fibroblast growth factor receptor 2 genes (reviewed by Kornblihtt, 2005). Two 
possible mechanisms can explain the effect of promoters on alternative splicing choices (see 
Kornblihtt, 2005). The factor recruitment mechanism by which the promoter itself is 
responsible for recruiting splicing factors (such as SR proteins) to the site of transcription, 
possibly through transcription factors that bind the promoter or the transcriptional enhancers. 
This mechanism is supported by the observation that promoter structure affected the 
responsiveness of EDI alternative splicing to the activation by the SR proteins SF2/ASF and 
9G8 (Cramer et al., 1999). In the other mechanism proposed, promoters can control 
alternative splicing via the regulation on RNA Pol II elongation rates or processivity. Studies 
of the effect of various transcriptional activators on the splicing of the FN EDI exon show that 
rapid, highly processive transcription favours EDI skipping, whereas slower, less processive 
transcription favours inclusion (Nogues et al., 2003). To explain this, a kinetic coupling 
model has been proposed (Caceres and Kornblihtt, 2002), where the transcript elongation rate 
determines the outcome of competing splicing reactions that occur co-transcriptionally. This 
has been directly shown in vivo, in human cells, using a mutant RNA Pol II with a lower 
elongation rate that it is able to affect alternative splicing of FN EDI exon and adenovirus E1a 
pre-mRNA (de la Mata et al., 2003). It was also shown in S. cerevisiae using a slow RNA Pol 
II mutant and inhibitors of RNA pol II elongation that changes in transcriptional elongation 
affected an alternatively spliced exon (Howe et al., 2003). 
There is now evidence indicating that not only the transcriptional machinery can 
influence splicing, but the splicing components can also influence the efficiency of 
transcription, indicating that there is much more extensive coupling between these processes 
than previously anticipated (see Rosonina and Blencowe, 2002). It has been shown that 
snRNPs associate with the human transcription elongation factor TAT-SF1, forming a 
complex that can stimulate both transcription and splicing (Fong and Zhou, 2001). This effect 
is likely to be mediated through the binding of TAT-SF1 to elongation factor P-TEFb. 
Inclusion of splicing signals in the nascent transcript further stimulates transcription, 
supporting the notion that the recruitment of U snRNPs near the elongating polymerase is 
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important for transcription. Because the TAT-SF1-U snRNP complex also stimulates splicing 
in vitro, it may serve as a dual-function factor to couple transcription and splicing and to 
facilitate their reciprocal activation (Fong and Zhou, 2001). But what could be the functional 
relevance of the reciprocal coupling between transcription and splicing? A typical mammalian 
gene contains nine introns and each intron can range in length from hundreds to tens of 
thousands of bases (Zorio and Bentley, 2004). By stimulating the transcription machinery, 
assembly of splicing factors at nascent 5′ splice sites might therefore help RNA Pol II to 
transcribe through a large intron sequence. This could be achieved by facilitating the 
recruitment of P-TEFb that helps to maintain the phosphorylation status of the CTD as 
hyperphosphorylated which is associated with it’s high processivity (Rosonina and Blencowe, 
2002). Ultimately, this mutual stimulation of transcription and splicing ensures that they act 
as a close couple, thereby facilitating efficient gene expression. 
 
Transcription and 3’ end processing 
The finding, back in the 80’s, that a poly(A) site is required for termination of RNA 
Pol II transcription was the first clue for the existence of communication between the RNA 
processing and transcription machineries (Falck-Pedersen et al., 1985; Logan et al., 1987; 
Whitelaw and Proudfoot, 1986). Many years passed until the nature of this communication 
started to be elucidated. Meanwhile, other connections between 3’ end processing and 
transcription started to be revealed, especially since the discovery of the CTD of RNA Pol II 
as a key player in connecting transcription and RNA processing. Experiments using 
transiently transfected cells showed that RNA molecules transcribed by CTD-truncated RNA 
Pol II were not efficiently polyadenylated (McCracken et al., 1997b). It was also shown that 
cleavage-polyadenylation factors CPSF and CstF present in unfractionated nuclear extracts 
specifically bound to CTD affinity columns and co-purified with RNA Pol II in a high-
molecular-mass complex (McCracken et al., 1997b). Unlike capping and splicing factors, 
CPSF and CstF bind independently of the phosphorylation status of the CTD. Surprisingly, 
the recruitment of cleavage-polyadenylation factors to nascent transcripts occurs not only at 
the 3’ end, but also at the promoter and throughout the length of the gene. ChIP experiments 
in yeast revealed that cleavage-polyadenylation factors are progressively recruited with a 
small but significant quantity at the 5’ end which increases toward the 3’ end (reviewed by 
Bentley, 2005). Accordingly, it has been shown that CPSF is brought to the pre-initiation 
complex by the general transcription factor TFIID and after transcription begins it dissociates 
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from TFIID and becomes associated with the elongating RNA Pol II (Dantonel et al., 1997). 
Furthermore, a biochemical study demonstrated that the CTD has a more direct role in 3’ end 
processing than just the recruitment of the machinery, as it was shown that it is essential for 
the cleavage step of the polyadenylation reaction in vitro in the absence of transcription 
(Hirose and Manley, 1998; Ryan et al., 2002). These results suggested that the CTD 
participates directly in the formation and/or function of a stable, catalytically active 
processing complex through direct interaction with cleavage-polyadenylation factors.  
As mentioned before, 3’ end processing and termination of transcription are intimately 
coupled. This coupling ensures that RNA Pol II is only released from the template after it has 
completed synthesis of a full-length transcript. Two basic models of how these two processes 
are coupled were put forward (Figure 5). The first, initially called “antiterminator” model but 
now also know as the “allosteric” model, invokes that upon recognition of the poly(A) signal 
in the nascent transcript an allosteric change in the transcription complex decreases the 
processivity of the elongating polymerase making it termination competent. This could be due 
to the dissociation of an antiterminator from the elongating complex or association of a factor 
that reduces processivity (Figure 5A) (Buratowski, 2005; Logan et al., 1987). The other 
model called the “torpedo” model originally suggested that cleavage of the nascent transcript 
at the poly(A) site initiated termination by promoting rapid degradation of the 3’ product still 
attached to the elongating polymerase. The 5’ uncapped end of the transcript would be an 
entry point for a 5’ to 3’ exonuclease that would chase down the polymerase and induce 
termination (Figure 5B) (Connelly and Manley, 1988; Proudfoot, 1989). Although both 
models try to explain the coupling between 3’ end processing and transcription termination, 
the “allosteric” model implies that termination is cleavage-independent whereas the “torpedo” 
model is based on the fact that termination is dependent on the cleavage reaction (reviewed by 
Rosonina et al., 2006).  
Studies over the past years provided evidence for both models and indicated that they 
may not be mutually exclusive. The “allosteric” model of termination was supported by 
electron microscopy studies of nascent transcripts in Xenopus oocytes (Osheim et al., 1999) 
and Drosophila (Osheim et al., 2002), where terminated but uncleaved RNAs could be 
observed. This model also received support from work in yeast in which termination occurred 
in the absence of the cleavage reaction (Sadowski et al., 2003). It was recently found that a 
protein called Pcf11 is able to dismantle the elongating complex both in yeast (Zhang et al., 
2005) and Drosophila (Zhang and Gilmour, 2006) in the absence of nucleotide hydrolysis. 
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Furthermore, yeast Pcf11 associates directly with both RNA and the CTD (Zhang et al., 
2005). It is therefore possible that conformational changes in the CTD could be transduced 
through Pcf11 to the nascent transcript to cause termination in response to transcription of the 
poly(A) signal. On the other end, the “torpedo” model received support from the observation 
that mutants defective in 3’ end cleavage were also defective in termination, providing 
evidence for a mechanism dependent on cleavage (Birse et al., 1998). Strong evidence for this 
model came also from the recent identification of the yeast Rat1 (Kim et al., 2004b) and the 
human Xrn2 (Gromak et al., 2006; West et al., 2004), both 5’ to 3’ RNA exonucleases 
necessary for efficient termination. Rat1 mutations strongly stabilize the RNA fragment 
downstream from the cleavage site and RNA Pol II fails to stop when it should (Kim et al., 
2004b). Similarly, depletion of Xrn2 from human cells using RNA interference (RNAi) 
impairs termination on a transiently transfected β-globin gene (West et al., 2004). A recent 
report showed that in yeast, nascent RNA is in fact co-transcriptionally degraded downstream 
of the poly(A) site and the exonuclease Rat1 contribute to this co-transcriptional degradation 
(Luo et al., 2006). Nevertheless, this degradation is not sufficient to cause polymerase release 
because it can occur without eliciting termination. Surprisingly, Rat1 was found to functions 
in both 3’ end processing and termination by enhancing recruitment of 3’ end processing 
factors, including Pcf11 and Rna15. In addition, the cleavage factor Pcf11 reciprocally aids in 
recruitment of Rat1 to the elongation complex (Luo et al., 2006). 
Analyses of the human β-globin gene indicated that, in addition to the normal 
cleavage/polyadenylation site, another cleavage site located downstream of the poly(A) site is 
important for transcription termination (Dye and Proudfoot, 2001). This site is co-
transcriptionally cleaved (Dye and Proudfoot, 2001) and therefore was named co-
transcriptional cleavage (CoTC) site (Figure 5C). It was recently shown that the RNA 
sequence at the CoTC forms a structure that has intrinsic self-cleavage activity in the absence 
of proteins, which is called an RNA enzyme or ribozyme (Teixeira et al., 2004). Mutations 
that inhibit self cleavage at the CoTC site also inhibit transcriptional termination. So far the 
CoTC element has only been described in primate β-globin genes (Teixeira et al., 2004), but it 
is possible that similar ribozymes may be present downstream of many other genes. In the 
presence of CoTC this is the entry site for the human 5’ to 3’ exonuclease Xrn2 (West et al., 
2004), whereas in its absence the entry site can still be the cleavage/polyadenylation site 
(Gromak et al., 2006). This is what happens in the case of the human C2 complement gene 
and the human β-actin gene that instead of a CoTC site possess an RNA Pol II pause site 
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(Gromak et al., 2006). The 3’ to 5’ exonucleolitic activity that degrades the upstream cleavage 
product in the presence of CoTC remains to be determined but one proposed possibility is a 
complex of 3’ to 5’ exonucleases called the exosome (Figure 5C) (West et al., 2006). 
 
 
 
Figure 5 - Models for transcription termination by RNA Pol II. The transcripts are 
represented by a green line, the cleavage and polyadenylation factors are represented by a red 
oval and proteins that are bound to the mRNA forming a messenger ribonucleoprotein particle 
(mRNP) are blue ovals. (A) The allosteric model. Transcription termination is caused by the 
destabilization and/or a conformational change of the RNA Pol II elongation complex after 
transcribing the poly(A) site. Release of antitermination factors (left) or recruitment of 
termination factors (right) triggers dissociation from template DNA. (B) The torpedo model. 
Endonucleolytic cleavage at the poly(A) site creates an entry site for the 5’ → 3’ exonuclease 
(Rat1 in yeast and Xrn2 in humans), which degrades the RNA downstream of the cleavage 
site. Short nascent RNA may induce arrest of RNA Pol II elongation complex and promote 
termination. (C) The torpedo model in the presence of a co-transcriptional cleavage (CoTC) 
site. Autocatalytic CoTC acts as a precursor to termination by presenting a free 5’ end that is 
recognised by the 5’ → 3’ exonuclease Xrn2. Subsequent degradation of this downstream 
cleavage product by Xrn2 leads to RNA Pol II transcriptional termination analogous to the 
original torpedo model shown in B. The 3’ end of the cleaved RNA is likely to be degraded 
by the exosome. Adapted from (Rosonina et al., 2006; West et al., 2004). 
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The importance of the Rat1 and Xrn2 5’ to 3’ exonucleases in termination of 
transcription indicates that a conformation change in the elongation complex, as proposed by 
the “allosteric” model, is insufficient to promote termination, and strongly supports the 
“torpedo” model. On the other hand, the dependence of efficient termination on the 
cleavage/polyadenylation site in addition to the CoTC (West et al., 2004), plus the recent 
evidence indicating that exonuclease digestion of the downstream RNA is not sufficient to 
trigger termination (Luo et al., 2006), argue against the “torpedo” model. One possibility that 
reconciles both models is that the RNA Pol II complex with which the 3’ end processing 
factors associated through the CTD achieves cleavage at the poly(A) site, degradation of the 
nascent downstream RNA, and undergoes allosteric changes that promote its release from the 
template (Rosonina et al., 2006; Tollervey, 2004). This is consistent with the fact that the 
efficiency of mRNA 3’ end processing appears to be unaffected by deletion of the CoTC 
element and, conversely, CoTC occurs in the absence of upstream 3’ end processing, but 
polymerase release from the DNA template requires both a functional poly(A) signal and 
CoTC (Dye and Proudfoot, 2001). The recent finding that the yeast Rat1 is not a dedicated 
termination factor, but is an integrated component of the cleavage/polyadenylation apparatus 
are also in agreement with this unified model for transcription termination (Luo et al., 2006). 
In addition to these biochemical links between factors recruited to the 5’ and 3’ ends 
of the gene, a physical connection between the promoter and poly(A) site has been reported in 
yeast (Ansari and Hampsey, 2005; O'Sullivan et al., 2004). These studies point to the 
existence of gene loops, in which the termination region of a transcriptionally active gene can 
be physically linked to its promoter site. In this situation, termination can additionally serve to 
facilitate transcriptional reinitiation by the same RNA Pol II. 
 
3.2 Interaction between processing steps 
 
There is evidence that the 5’ cap bound by cap binding complex (CBC) is implicated 
in interactions with splicing components at the adjacent 5' splice site for removal of the first 
intron (reviewed by Proudfoot et al., 2002). The mammalian CBC is required for efficient 
recognition of the cap-proximal 5' splice site by U1 snRNP during early spliceosome 
formation (Izaurralde et al., 1994; Lewis et al., 1996). Additional research suggested that the 
CBC positively influences the U6 snRNA 5’ splice site interaction, possibly by affecting the 
displacement of U1 snRNP by U6 (O'Mullane and Eperon, 1998). In the yeast S. cerevisiae 
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conditional inactivation of Ceg1 resulted in an increase in the amount of unspliced pre-mRNA 
in vivo, demonstrating that these interactions are conserved in evolution (Fresco and 
Buratowski, 1996; Schwer and Shuman, 1996). Recent experiments in yeast show that the 
CBC is necessary, but not sufficient, for co-transcriptional spliceosome assembly 
(Gornemann et al., 2005). 
Several reports have demonstrated that 3’ end processing is coupled to the splicing of 
the terminal intron of a gene (reviewed by Proudfoot et al., 2002). This coupling was first 
reported in an in vitro study where it was shown that polyadenylation was stimulated by the 
upstream intron and this stimulation required a 3' splice site but not a 5' splice site (Niwa et 
al., 1990). Reciprocally, it was shown that mutation of the AAUAAA polyadenylation 
consensus sequence inhibited in vitro splicing of an upstream intron but not the removal of 
introns further upstream (Cooke et al., 1999; Niwa and Berget, 1991). These early 
observations of the dependence of splicing on polyadenylation signals and vice versa 
suggested the existence of interaction between polyadenylation and splicing factors.  
In vivo studies indicated that the second and last intron of the human β-globin pre-
mRNA was also necessary for correct and efficient 3’ end formation (Collis et al., 1990). 
Further analysis indicated that efficient 3’ end formation of the human β-globin transcripts is 
strongly enhanced by the presence of the terminal 60 nucleotides of the last intron (Antoniou 
et al., 1998). Specifically, mutations in the intronic polypyrimidine (Py) tract reduce 3’ end 
processing efficiency in vitro and in vivo (Cooke and Alwine, 2002; Cooke et al., 1999; 
Millevoi et al., 2002). The Py tract is recognised by U2AF65 at an early step in the assembly 
of the spliceosome and in addition to its crucial role in splicing, U2AF65 binding to the Py 
tract of the last intron of the human β-globin pre-mRNA promotes 3’ end processing 
(Millevoi et al., 2002). Additional studies on the mechanisms by which U2AF65 stimulates 
pre-mRNA 3’ end processing led to the identification of an interaction between U2AF65 and a 
subunit of the human cleavage factor I (CF Im) (Millevoi et al., 2006). Tethered functional 
analysis showed that the U2AF65/CF Im interaction stimulates in vitro 3’ end cleavage and 
polyadenylation. There is also evidence that the 3’ end processing machinery is able to 
stimulate splicing. It was shown that PAP can stimulate splicing through its interaction with 
U2AF65 and as a consequence of this interaction there is increased binding of U2AF65 to the 
Py tract of the 3’ splice site adjacent to the 3’ end formation signals (Vagner et al., 2000). 
Taken together these results suggest a major role for U2AF65 in the coupling between splicing 
of the last intron and 3’ end processing. In conclusion, U2AF65 has been implicated in both 
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the stimulation of splicing by the 3’ end processing machinery through it’s binding to PAP 
(Vagner et al., 2000) and in the stimulation of 3’ end processing by the splicing machinery 
through its binding to CF Im (Millevoi et al., 2006). 
 
3.3 Coupling transcription and processing with mRNA export 
 
Splicing and mRNA export 
The first evidence suggesting that splicing can enhance the efficiency of mRNA export 
came from the demonstration that pre-mRNA molecules containing a single intron are 
exported more efficiently from microinjected Xenopus oocyte nuclei than the same RNA 
molecules lacking the intron (Luo and Reed, 1999). Furthermore, an in vitro spliced mRNA 
and a cDNA version of the same RNA, though identical in sequence, were assembled into 
different mRNPs and only the spliced mRNP was exported rapidly and efficiently from 
injected oocyte nuclei (Luo and Reed, 1999). Based on these experiments the authors 
concluded that intron removal appeared to lead to the deposition of specific proteins that 
targeted the spliced mRNA for efficient nuclear export. The direct evidence that pre-mRNA 
splicing alters mRNP protein composition came one year later with the use of a novel in vitro 
cross-linking approach which allowed the identification of several proteins that associated 
with the mRNA exon-exon junctions as a consequence of splicing (Le Hir et al., 2000b). 
Further studies showed that the spliceosome stably deposits several proteins on the mRNA, 
probably as a single complex, that protects 8 nucleotides of the mRNA at a conserved position 
20-24 nucleotides upstream of exon-exon junctions, in a sequence-independent manner (Le 
Hir et al., 2000a). Initial immunoprecipitation experiments revealed that this complex, called 
exon junction complex (EJC), was composed by the splicing-associated factors SRm160, 
DEK and RNPS1, UAP56, the mRNA-associated shuttling protein Y14 and the mRNA export 
factor REF1/Aly (Kataoka et al., 2000; Le Hir et al., 2001; Le Hir et al., 2000a; Luo et al., 
2001). In the following years several other proteins were found to be part of this complex, like 
the Y14 partner Magoh (Kataoka et al., 2001), the nonsense-mediated mRNA decay (NMD) 
factors Upf3a/b, Upf2 and Upf1 (Le Hir et al., 2001; Lykke-Andersen et al., 2001), the 
nuclear translation-like factor eIF4AIII, a member of the DExH/D-box family of NTP-
dependent RNA binding proteins (Ferraiuolo et al., 2004; Shibuya et al., 2004), the 
nucleocytoplasmic shuttling protein MLN51 (also known as Barentsz, Btz) which is 
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overexpressed in breast cancer (Degot et al., 2004), the RNP1 interacting protein Pinin (Li et 
al., 2003), SAP18, a shuttling protein, and Acinus, a protein restricted to the nucleus (Tange 
et al., 2005). The EJC is a highly dynamic structure consisting of a few core proteins plus 
several more peripherally associated factors (Figure 6). The core of the EJC is composed of 
four proteins: eIF4AIII, Y14, Magoh and MLN51. These proteins form a stable 
heterotetramer that remains bound to the mRNA throughout many different cellular 
environments (Tange et al., 2005), with eIF4AIII providing direct contact to the mRNA 
(Shibuya et al., 2004). All factors in this core are shuttling proteins and most likely follow the 
mRNA to the cytoplasm (Tange et al., 2005). Proteins in the outer shell were all found by 
mass spectrometry of an in vitro-derived EJC (Tange et al., 2005). RNPS1, Acinus, and 
SAP18 can stably associate (Schwerk et al., 2003) and may bind the EJC core as a trimeric 
complex. However, RNPS1 may also bind alone, via interactions with Pinin (Sakashita et al., 
2004). SAP18, RNPS1, and REF1/Aly are shuttling proteins (Lykke-Andersen et al., 2001; 
Tange et al., 2005; Zhou et al., 2000), whereas Acinus and Pinin are nuclear restricted (Li et 
al., 2003; Tange et al., 2005). Transiently interacting factors are proteins not identified in an 
in vitro-derived EJC, but which likely interact dynamically with either the EJC core or outer 
sphere proteins (Tange et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Three spheres of exon junction complex (EJC) factors. The minimal EJC core 
likely consists of a tetrameric complex containing eIF4AIII, MLN51, Magoh, and Y14 (Tange 
et al., 2005). Proteins in the outer shell were all found by mass spectrometry of the in vitro-
derived EJC (Tange et al., 2005). Transiently interacting factors are proteins not identified in 
the in vitro-derived EJC, but are likely to interact dynamically with either the EJC core or the 
outer shell proteins (see text for more details). Adapted from (Tange et al., 2005). 
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Despite being the focus of intense research, the assembly pathway of the EJC is still 
poorly understood. In human cells, the EJC is assembled during the second step of splicing, 
when the lariat has been formed and the exons are being ligated (Reichert et al., 2002; 
Shibuya et al., 2004). It was reported that numerous proteins interact with the 5’ exon in the 
catalytically active spliceosome and during exon ligation, a major restructuring of this region 
occurs, placing three other proteins (p170, p95 and p57) at the site where the EJC forms 
(Reichert et al., 2002). At least one EJC component, REF1/Aly, can interact with the pre-
mRNA prior to spliceosome assembly, whereas Y14, Magoh, RNPS1, UAP56, and SRm160 
were found in intermediate-containing spliceosomes. Upon exon ligation, association of 
RNPS1, UAP56, and SRm160 is destabilized. In contrast, REF1/Aly, Y14, and Magoh remain 
stably bound to spliced mRNA (Reichert et al., 2002). Once formed, the EJC is associated 
with mRNA molecules that are bound by the nuclear cap-binding protein CBP80, both in the 
nucleus and in the cytoplasm, but not with mRNA molecules bound by the cytoplasmic eIF4E 
cap-binding protein, suggesting that at least part of the EJC is exported and then dissociates 
from the mRNA in the cytoplasm (Lejeune et al., 2002).  
The nature of the proteins identified in the EJC led to the proposal of several functions 
for the EJC at different steps of mRNA metabolism, including nucleocytoplasmic transport of 
spliced mRNA, NMD (the degradation of mRNAs containing premature stop codons), mRNA 
localisation in the cytoplasm and translational yield of mRNA (reviewed by Tange et al., 
2004). The complex is believed to be eventually removed by ribosomes in the first round of 
translation (Lejeune et al., 2002). 
The notion that EJC deposition leads to recruitment of the mRNP export factor NXF1 
(TAP) is an attractive model to explain the stimulatory effect of splicing on export. Evidence 
for this model came from an initial study showing that the EJC provides a binding platform 
for the mRNA export factors REF1/Aly and NXF1-NXT1 (also known as TAP-p15) (Le Hir 
et al., 2001). It was also shown in metazoan cells that REF1/Aly is specifically recruited to 
mRNPs generated by splicing (Zhou et al., 2000) and interacts with the spliceosomal protein 
UAP56 (Luo et al., 2001). Furthermore, recruitment of REF1/Aly to spliced mRNAs depends 
on the interaction with UAP56 (Luo et al., 2001) and REF1/Aly also interacts directly with 
NXF1 (Rodrigues et al., 2001; Stutz et al., 2000; Zhou et al., 2000). Therefore, a possible 
explanation for the splicing dependent recruitment of NXF1-NXT1 in metazoan cells is that 
during splicing UAP56 facilitates spliceosome assembly and then recruits REF1/Aly that in 
turn recruits the NXF1-NXT1 heterodimer, which then targets the spliced mRNPs to the NPC 
37 
Introduction 
(reviewed by Cullen, 2003). In metazoans, where most genes contain introns, it makes perfect 
sense that the conserved machinery for mRNA export is intimately tied to splicing. But could 
this also occur in S. cerevisiae, where only a few genes contain introns? Experimental 
evidence indicates that it is possible that both splicing dependent recruitment of the mRNA 
export machinery and EJC formation are conserved in yeast. In S. cerevisiae, the counterparts 
of REF1/Aly (Yra1p) and UAP56 (Sub2p) also interact with each other directly and are 
required for mRNA export (Strasser and Hurt, 2001) and Yra1p also interacts directly with the 
yeast ortholog of metazoan NXF1 (Mex67p) (Strasser and Hurt, 2000).  
A new set of experiments using an RNA interference (RNAi) approach both in 
Drosophila cells and in C. elegans brought some confusion to the emerging picture of a 
conserved mRNP export pathway linked to the EJC (the UAP/REF/NXF1 pathway). The 
conclusions of the RNAi study in Drosophila were that although NXF1, NXT1 and UAP56 
were required for mRNA export (Gatfield and Izaurralde, 2002; Herold et al., 2001; Herold et 
al., 2003), REFs and the other EJC components were dispensable (Gatfield and Izaurralde, 
2002). The conclusions of the C. elegans study were similar with NXT1 being required for 
mRNP export but the REF proteins (there are three REF proteins present in C. elegant) and 
several EJC proteins being dispensable (Longman et al., 2003). There are several possibilities 
to explain these results: either the RNAi-mediated knockdown of REF and the other EJC 
proteins was not sufficient to eliminate their functions or there may be a redundancy in factors 
(Reed, 2003). Another possibility is that the splicing dependent recruitment of the export 
factors to the mRNPs is not essential for export but it increases the efficiency and/or fidelity 
of the process by promoting a more efficient recruitment (Ohno et al., 2002). The authors of 
the above studies favour yet another possibility. They propose that other adaptor protein(s) 
may mediate the interaction between NXF1 and the mRNA. In agreement with this 
hypothesis, members of the SR family of splicing factors have been proposed to fulfil this role 
(reviewed by Reed and Cheng, 2005). In metazoans, these proteins bind to exon sequences in 
pre-mRNA and recruit the spliceosome to the flanking 5’ and 3’ splicing sites. After splicing, 
SR proteins remain bound to the spliced mRNA (see Graveley, 2000) and shuttle between the 
nucleus and cytoplasm (Caceres et al., 1998) as would be expected of an mRNA export 
protein. In fact, it was shown that the SR proteins 9G8 and SRP20 mediate mRNA export 
(Huang and Steitz, 2001) and function by direct interaction with NXF1 (Huang et al., 2003). 
Furthermore, it was shown that phosphorylation of the SR proteins is involved in regulating 
their interaction with NXF1 (Huang et al., 2004). Specifically, the dephosphorylated form of 
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SR proteins associates with mRNA and with NXF1 and thus this dephosphorylation is 
thought to be a mechanism for the selective export of spliced mRNA versus unspliced pre-
mRNA (Huang et al., 2004). 
 
Transcription and mRNA export 
Although the UAP/REF/NXF1 export machinery seems to be conserved from yeast to 
humans, it cannot be exclusively recruited by a splicing-dependent mechanism. In fact, 95% 
of S. cerevisiae genes as well as several metazoan genes lack introns. Accordingly, it was 
shown that the S. cerevisiae Sub2p and Yra1p (human UAP56 and REF1/Aly, respectively) 
are essential for nuclear export of the intronless mRNPs (Jensen et al., 2001a; Strasser and 
Hurt, 2000; Strasser and Hurt, 2001) and Yra1p binding to mRNPs can occur in the absence 
of splicing (Lei and Silver, 2002a). In metazoan cells, recruitment of UAP56 to mRNPs has 
also been shown to occur independently of splicing (Kiesler et al., 2002) and knockdown of 
either UAP56 or NXF1 by RNAi blocks the nuclear export of both spliced and intronless 
transcripts (Gatfield et al., 2001; Herold et al., 2001). Thus, a central focus of recent research 
has been to determine the mechanisms for splicing-independent recruitment of this 
machinery. One hypothesis that has been proposed is that transcription itself can promote the 
recruitment of nuclear export factors.  
The first evidence for this hypothesis came from ChIP experiments in S. cerevisiae 
showing that the mRNA export machinery is recruited co-transcriptionally (Lei et al., 2001). 
New evidence came from the finding that Sub2p and Yra1p are stoichiometrically associated 
with the yeast THO complex (Strasser et al., 2002). This complex was previously identified as 
a four protein complex, composed of stoichiometric amounts of Tho2, Hpr1, Mft1 and Thp2 
and shown to be involved in transcription elongation and the maintenance of genome stability 
(Chávez et al., 2000). The THO complex together with the mRNA export proteins was 
designated “transcription/export” (TREX) complex (Strasser et al., 2002). It was also shown 
that Sub2 and Yra1 interact genetically with all four components of the THO complex and 
that these components operate in the export of bulk poly(A)+ RNA as well as of mRNA 
derived from intronless genes. Both REF1/Aly and UAP56 associate with human counterparts 
of the THO complex suggesting that the TREX complex has a conserved role in coupling 
transcription to mRNA export (Strasser et al., 2002). Further studies showed that the THO 
component Hpr1 interacts directly with Sub2p and plays a role in recruiting Sub2p and Yra1p 
to actively transcribed genes (Zenklusen et al., 2002). In a genetic screen in S. cerevisiae, an 
39 
Introduction 
interaction between Yra1p and the conserved protein Sac3p was identified (Fischer et al., 
2002). Sac3p was previously found to interact with Sub2p (Strasser et al., 2002), form a stable 
complex in vivo with Thp1p, a protein previously reported to function in transcription 
elongation (Fischer et al., 2002) and bind to the mRNA export factor Mex67p-Mtr2p (human 
NXF1-NXT1) (Fischer et al., 2002; Lei et al., 2003). Moreover, Sac3p interacts with the 
nucleoporin Nup1p located at the nuclear side of the nuclear pore complex (NPC) (Fischer et 
al., 2002). Immunoelectron microscopy analysis showed that Sac3p localises exclusively to 
cytoplasmic fibrils of the NPC and Mex67 accumulates at the nuclear rim when SAC3 is 
mutated (Lei et al., 2003). Significantly, mutations in Sac3p or Thp1p lead to strong mRNA 
export defects (Fischer et al., 2002; Lei et al., 2003). On the basis of these observations, a 
model can be proposed in which Sac3p first associates with the mRNP early in its formation, 
perhaps during transcription, and then by interacting with both Mex67p and the nucleoporin, 
facilitates docking of the mRNP at the NPC and functions in the translocation of Mex67p 
across the NPC (Fischer et al., 2002; Lei et al., 2003). Metazoan counterparts of Sac3 and 
Thp1 have been identified. Thus, it would not be surprising if these proteins played also a role 
in mRNA export in metazoans. 
 ChIP assays revealed that THO complex components, as well as Yra1p and Sub2p, are 
recruited to actively transcribed genes during transcription and travel the entire length of the 
gene with RNA Pol II (Abruzzi et al., 2004; Strasser et al., 2002; Zenklusen et al., 2002). A 
modified ChIP assay that includes an RNase step indicates that Sub2p binds to nascent RNA, 
Yra1p associates with both RNA and DNA, and Hpr1p associates only with DNA (Abruzzi et 
al., 2004). Although Hpr1p was found to be recruited similarly to both intronless and intron-
containing genes, low Yra1p and Sub2p levels were present on a subset of intron-containing 
genes. The residual Yra1p and Sub2p recruitment was less RNA-associated and showed a 
good correlation with high levels of U1 snRNP on these genes. These experiments support a 
model in which TREX is recruited via the transcription machinery and then Yra1p and Sub2p 
are transferred to the nascent RNA (Figure 7A). On some intron-containing genes, retention 
and/or transfer of Yra1p and Sub2p to nascent RNA seems to be inhibited (Abruzzi et al., 
2004). 
The Drosophila counterpart of the THO complex was identified and contains 
homologs of Tho2 and Hpr1 as well as three proteins, THOC5, THOC6 and THOC7, which 
do not have apparent yeast homologs (Rehwinkel et al., 2004). RNAi showed that the 
Drosophila THO complex functions in mRNA export but genome-wide studies led to the 
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conclusion that the vast majority of mRNAs are transcribed and exported independently of the 
THO complex (Rehwinkel et al., 2004). 
 
 
 
Figure 7 - Models for “transcription/export” (TREX) complex recruitment. (A) Co-
transcriptional recruitment of the TREX complex in yeast. mRNA export proteins Yra1 (Y), 
Sub2 (S) associate with the THO complex to form the TREX complex. This complex is 
recruited to active genes and functions to load Yra1 and Sub2 onto the nascent transcript. (B) 
Recruitment of the human TREX complex during splicing. The hTREX complex is composed 
by the hTHO complex, UAF56 (U) and REF1/Aly (A). Spliceosome assembly and splicing 
occur as the transcript is synthesized by RNA Pol II and the hTREX complex is recruited to 
the spliced mRNA near the 5’ end, with REF1/Aly bound closest to the cap binding complex 
(CBC). For simplicity, other components of the spliced mRNP, such as EJC proteins, are not 
shown. Adapted from (Masuda et al., 2005; Reed and Cheng, 2005). 
 
Recently, the human TREX complex was characterised in detail and shown to contain 
REF1/Aly, UAP56 and the human counterpart of the THO complex (Masuda et al., 2005). 
Surprisingly, in vitro studies indicate that the human THO complex associates with spliced 
mRNA but not with unspliced pre-mRNA and this association is independent of transcription 
(Masuda et al., 2005). These new data suggests that in humans, recruitment of the TREX 
complex to spliced mRNA is not directly coupled to transcription as it is in yeast, but is 
instead coupled to splicing and only indirectly to transcription because splicing in humans is a 
co-transcriptionally event (Masuda et al., 2005). Assuming that this splicing-coupled 
mechanism also occurs in vivo in human cells, one hypothesis that could reconcile these 
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results with what was shown in yeast is that there are two mechanisms for TREX complex 
recruitment: a splicing-coupled more prevalent in metazoans, and a direct transcription 
coupled, more common in yeast (Figure 7). These mechanisms may differ in yeast versus 
metazoans because most yeast genes lack introns (for review see Reed and Cheng, 2005). 
Recent data (Cheng et al., 2006) helped to understand better the splicing-coupled mechanism 
of TREX recruitment in human cells. This study revealed that the human TREX complex is 
recruited in a splicing- and cap-dependent manner to a region near the 5’ end of the mRNA 
with the TREX component REF1/Aly bound closest to the 5' cap (Figure 7B). The CBP80, 
which is bound to the cap, associates efficiently with TREX, and REF1/Aly mediates this 
interaction suggesting that CBP80-REF1/Aly interaction results in recruitment of TREX to 
the 5' end of mRNA, where it functions in mRNA export (Cheng et al., 2006). 
 
3’ end processing and mRNA export  
Several studies have demonstrated a connection between mRNA 3’ end processing 
and export. In human cells, mRNA molecules bearing 3’ ends formed by a self-cleaving 
ribozyme element were only detected in the nucleus, indicating that they were not efficiently 
exported to the cytoplasm (Eckner et al., 1991; Huang and Carmichael, 1996). Indeed, the 
proper completion of 3’ end formation is required for efficient nuclear export of mammalian 
mRNAs and it appears that it is the process of polyadenylation, and not merely the presence 
of a poly(A) tail, that is crucial for the generation of an export-competent mRNA (Eckner et 
al., 1991; Huang and Carmichael, 1996). 
In S. cerevisiae two observations initially suggested that the transport of the mRNA 
from the nucleus to the cytoplasm is also sensitive to proper 3’ end formation, including 
polyadenylation. First, mRNAs lacking a proper 3’ end formation signal accumulated within 
the nucleus (Long et al., 1995). Second, fluorescent labelling of specific transcripts in living 
yeast cells demonstrated their nuclear accumulation when assayed in strains defective in 3’ 
end formation (Brodsky and Silver, 2000). In an effort to understand mRNA export and its 
relationship to other aspects of mRNA metabolism, numerous mutants that affect mRNA 
export in yeast were isolated. These mRNA export mutants were identified by several criteria, 
including screenings for lesions that result in the nuclear accumulation of polyadenylated 
RNA. These screenings led to the identification of genes important for ribonucleic acid 
trafficking (RAT), mRNA transport (MTR) and mRNA export (MEX) (see Hilleren and 
Parker, 2001). Yeast strains carrying lesions in several of these genes produce nascent 
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transcripts carrying poly(A) tails roughly 30 residues longer than the nascent poly(A) tails 
observed in wild-type strains (Hilleren and Parker, 2001). Furthermore, several factors 
involved in termination and 3’ end processing were also obtained in a screening to identify 
genes required for mRNA export in yeast (Hammell et al., 2002). Taken together these 
observations provide support for the view that, at least in yeast, mRNA 3’ end formation and 
mRNA export are mechanistically coupled events. 
Although substantial evidence indicate that in yeast the mRNA export machinery is 
co-transcriptionally loaded onto mRNA, 3’ end formation may play a more critical role in this 
loading. For example, Sub2p is not required for the recruitment of Yra1p to genes that lack 
introns. However, proper 3’ end formation is required to recruit this factor, whether or not an 
intron is present (Lei and Silver, 2002a). In further support of this view it was reported that 
transcripts generated by T7 polymerase (i.e. not by RNA Pol II) are exported only if 3’ end 
formation occurs normally (Dower and Rosbash, 2002).  
Although all these data clearly indicate some form of tight mechanistic coupling 
between mRNA 3’ end formation and nuclear export, its molecular basis remains unresolved. 
 
 
4. Integrating gene expression with nuclear architecture 
 
Most of the knowledge collected on each step of gene expression came from 
biochemical experiments, where they were studied individually. Discoveries within the last 
decade have revealed that the multiple steps in gene expression are remarkably coupled and 
this coupling must reflect their spatial organisation inside the cell. For this reason, a better 
understanding of gene expression must take into account its natural cellular context and in 
particular the nuclear architecture. Cell biological approaches are essential to study gene 
expression in vivo, since they allow analysis of gene expression at the single cell level, in 
living cells and in a spatial and temporal context.  
 
4.1 The concept of sub-nuclear compartments 
 
It is now accepted that the nucleus is a highly dynamic and organised organelle, 
functionally and spatially compartmentalised (reviewed by Misteli, 2000; Misteli, 2005; 
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Misteli, 2008). The interphase nucleus can be divided into chromatin containing regions and 
interchromatin nucleoplasmic space. In the chromatin regions each chromosome occupies a 
nuclear space or territory and specific DNA sequences within each chromosome are organised 
as either euchromatin (less condensed genome regions) or heterochromatin (highly condensed 
regions) (Meaburn and Misteli, 2007). The classic view correlates chromatin morphology 
with gene activity, where euchromatin is considered to be transcriptionally active and 
heterochromatin considered transcriptionally silenced (reviewed by Cremer and Cremer, 
2001). A recent study, however, found a better correlation between chromatin morphology 
and gene density, with gene-rich regions being present in open chromatin regions and gene-
poor regions in more condensed chromatin (Gilbert et al., 2004).  
In the interchromatin space several sub-nuclear compartments may form. The best 
characterised is the nucleolus, the site of rRNA synthesis. In addition, several nuclear bodies, 
often referred as foci, because of their appearance by fluorescence microscopy, are present in 
the nucleus. The best characterised nuclear bodies are the Cajal body (involved in snRNP 
biogenesis) and the PML body (promyelocytic leukaemia body, riche in transcriptional 
regulators) (reviewed by Zhong et al., 2000). Additional compartments that occupy a large 
volume of the interchromatin nucleoplasmic space are the splicing factor compartments (SFC) 
also called speckles because of their irregular shape when detected by immunofluorescence 
using anti-splicing factor antibodies. By electron microscopy the SFC correspond to two 
distinct structures that cannot be distinguished by fluorescence microscopy, the 
interchromatin granule clusters (IGC) and the perichromatin fibrils (Spector, 1993).  The IGC 
are composed of clusters of 20-25 nm in diameter that seem to be connected by a thin fibril. 
The perichromatin fibrils are fibrillar structures of 3-5 nm in diameter found at the periphery 
of IGC. Several lines of evidence point to IGC as storage/ assembly/ modification 
compartments that can supply splicing factors to active transcription sites (reviewed by 
Lamond and Spector, 2003). Live-cell studies show that splicing factors are recruited from 
IGC to sites of transcription (Misteli et al., 1997). When transcription or pre-mRNA splicing 
are inhibited, splicing factors accumulate in enlarged, rounded IGC (Spector et al., 1983) 
(O'Keefe et al., 1994). Thus, the IGC are dynamic structures that change in response to the 
transcriptional activity of the cell.  
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4.2 Organisation of RNA polymerase II transcription sites in the nucleus 
 
The first experiments that allowed the visualisation of transcriptional activity in the 
mammalian nucleus consisted of short pulses of tritiated uridine that were analysed at the 
electron microscopic level. These experiments showed that nascent pre-mRNA is 
predominantly localised in the perichromatin fibrils at the periphery of IGCs and in other 
regions throughout the nucleoplasm (reviewed by Fakan, 1994). More recent results using 
incorporation of bromouridine triphosphate (Br-UTP) that can be detected by 
immunolabelling and visualised at the fluorescence or electron microscope allowed a more 
detailed analysis of transcription sites. These experiments showed that the transcription sites 
appear as discrete foci throughout the nucleoplasm and confirm their association with 
perichromatin fibrils. RNA Pol II itself is also distributed widely throughout the nucleoplasm 
in many discrete sites that frequently coincides with the foci of labelled nascent transcripts 
(reviewed by Szentirmay and Sawadogo, 2000). The number of RNA Pol II transcription sites 
in HeLa cells has been estimated using different RNA labelling and cell preparation methods 
and combining fluorescence and electron microscopy. These experiments provided an 
estimate of several thousand transcription foci for RNA Pol II in each HeLa cell nucleus (see 
Szentirmay and Sawadogo, 2000). An estimate of the number of active polymerases 
determined that each focus may contain 8-15 transcription polymerases giving rise to the 
proposal that RNA Pol II associates into “transcription factories” (reviewed by Cook, 1999; 
Pombo et al., 2000). This could represent a way to increase the local concentration of 
transcription factors and RNA Pol II at sites of active transcription. The observation that 
active RNA Pol II transcription units are resistant to electroelution, even after the removal of 
most of the chromatin, supports a model in which the polymerases are attached in the nucleus 
(Iborra et al., 1996; Jackson et al., 1996). According to this model, the genes are recruited to 
and transcribed by attached polymerases. The loops of chromatin surround the transcription 
factories and the DNA moves past the attached polymerases during transcription (Iborra et al., 
1996). 
 
4.3 Pre-mRNA processing within the nucleus 
 
Pre-mRNA processing was initially considered a post-transcriptional process but there 
is now definitive biochemical, cytological and genetic evidence that much of the pre-mRNA 
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processing takes place co-trancriptionally (see Szentirmay and Sawadogo, 2000). The first 
unambiguous demonstration that pre-mRNA splicing takes place co-trancriptionally was 
provided by electron micrographs of Miller chromatin spreads of Drosophila embryo genes, 
where ribonucleoprotein particle formation and intron removal could be seen on nascent 
transcripts (Osheim et al., 1988). In mammalian cells, Fakan et al. (Fakan et al., 1986) 
localised snRNPs to elongating RNP fibrils and in Chironomus tentans the spliceosomes were 
found to be associated with nascent RNA molecules transcribed from the Balbiani ring genes 
(Kiseleva et al., 1994). 
There were for some time discrepancies in the literature concerning the possible direct 
role of SFC as splicing sites, but there is now substantial evidence that co-transcriptional 
splicing is associated with perichromatin fibrils, rather than, with IGC. These discrepancies 
might have arisen essentially for two reasons. Firstly, because it is not possible to distinguish 
perichromatin fibrils from IGC, using fluorescence microscopy. Secondly, because in these 
studies highly transcribed genes were used and they recruit a significant amount of pre-
mRNA splicing factors, making these regions indistinguishable from IGC in the fluorescence 
microscope (Lamond and Spector, 2003).  
Several experimental approaches indicate that, rather than being sites of active 
splicing, the SFC/IGC function mostly as storage compartments that can supply splicing 
factors to active transcription sites (see Misteli and Spector, 1998)). The first clues for the role 
of SFC/IGC in splicing came from work on adenovirus-infected cells. During intermediate 
stages of infection, viral transcripts accumulate in the interchromosomal space and it was 
observed that splicing factors also accumulate at these sites of viral infection, resulting in 
reduced SFC. These experiments let to the proposal that splicing factors are recruited from 
SFC to sites of active transcription upon transcriptional activation of genes (reviewed by 
Misteli and Spector, 1998). These results were later confirmed using transfected DNA 
templates encoding either intron-containing or intronless transcripts in which the splicing 
factors were only localised to the sites of intron-containing transcripts (Huang and Spector, 
1996). Taking advantage of the green fluorescent protein (GFP), this recruitment model was 
directly tested in living cells by the visualisation of the dynamic properties of the pre-mRNA 
splicing factor SF2/ASF by time-lapse microscopy. These experiments showed that upon 
activation of genes, splicing factors moved from SFC to newly formed sites of transcription 
(Misteli et al., 1997). Based on the previously described experimental evidence, a model was 
proposed to explain the spatial organisation of pre-mRNA splicing in the mammalian cell 
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nucleus. In a transcriptionally active nucleus splicing factors localised in IGC represent 
storage sites while the splicing factors present in perichromatin fibrils are actively engaged in 
splicing. In response to transcriptional activity the splicing factors are recruited from IGC to 
perichromatin fibrils. 
 
4.4 Dynamics of mRNA within the nuclear environment 
 
After being released from the transcription sites, mRNA molecules must reach the 
NPC in order to be translocated to the cytoplasm for translation. How the mRNA molecules 
travel from the transcription site to the nuclear pore remains the subject of most investigation 
and is in general poorly understood (reviewed in Darzacq et al., 2005; Gorski et al., 2006; 
Misteli, 2008; Shav-Tal et al., 2006). As previously mentioned, during processing nascent 
mRNA molecules assemble together with RNA binding proteins into ribonucleoprotein 
particles (mRNPs). Because the intranuclear environment is very viscous, the simple diffusion 
of large macromolecular complexes such as mRNPs, was expected to be too slow to explain 
the fact that mRNAs could be detected in the cytoplasm within a few minutes after their 
synthesis. Therefore, the hypothesis that active genes are situated near the nuclear periphery 
and that mRNAs exit the nucleus through the nearest pores (known as the “gene gating” 
hypothesis) was proposed (Blobel, 1985). However, the development of new tools to study 
the movement of molecules in the nucleus such as photobleaching and fluorescence 
correlation spectroscopy techniques have indicated that macromolecule-sized solutes can 
diffuse in the nucleus at rates that are only approximately three- to fourfold slower than those 
observed in aqueous solution (Politz et al., 1998; Seksek et al., 1997). Reports addressing 
specifically the movement of nuclear mRNPs indicate that they move from the sites of 
transcription to the nuclear pores by a diffusion-based mechanism (Calapez et al., 2002; 
Molenaar et al., 2004; Politz et al., 1998; Politz et al., 1999; Shav-Tal et al., 2004; Snaar et al., 
2002; Vargas et al., 2005), although energy dependent processes may also be involved 
(Calapez et al., 2002; Shav-Tal et al., 2004; Vargas et al., 2005). Diffusion coefficients from 
0.01 to 0.6 μm2s-1 have been estimated for nuclear mRNPs using labelling methods based 
either on fluorescent oligonucleotide probes (Molenaar et al., 2004; Politz et al., 1998; Politz 
et al., 1999; Vargas et al., 2005) or specific mRNA binding GFP-fused proteins (Calapez et 
al., 2002; Shav-Tal et al., 2004). Tracking of a single mRNP in the nucleoplasm of living 
mammalian cells indicated that it moves freely by Brownian diffusion (Shav-Tal et al., 2004; 
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Vargas et al., 2005). Furthermore, the diffusion of mRNPs is restricted to the extranucleolar, 
interchromatin spaces and if the mRNPs move into dense chromatin, they tend to become 
stalled. In this situation ATP is required for the complexes to resume their motion, but the 
movement of mRNPs does not require energy (Shav-Tal et al., 2004; Vargas et al., 2005).  
 
 
5. Quality control mechanisms of gene expression in the nucleus 
 
The accurate function of all the molecular machines in a cell depends on the integrity 
of their protein components which is directly related to both genome integrity and accuracy of 
all the steps of gene expression. Aberrant transcripts can arise from mutations in the genomic 
sequences or from errors generated during several steps of mRNA biogenesis. Recent studies 
revealed a complex network of interactions between components of the gene transcription, 
pre-mRNA processing, mRNA transport and mRNA translation machineries. Besides 
providing the means to regulate gene expression at many different levels, these interconnected 
processes provide also opportunities for quality control checkpoints, so that only fully 
processed and error-free mRNAs are translated into proteins (reviewed by Fasken and 
Corbett, 2005; Saguez et al., 2005; Sommer and Nehrbass, 2005).  
The classical example of a quality control mechanism of gene expression is the 
recognition and degradation of transcripts harbouring premature termination codons, also 
known as nonsense-mediated decay (NMD). In fact, for a long time this was the only known 
mechanism of mRNA quality control or mRNA surveillance and is still the best well 
documented in several experimental systems. In recent years a number of mRNA quality 
control checkpoints which operate at different levels of mRNA biogenesis both in the nucleus 
and in the cytoplasm have been identified and this is currently a field of intense research (see 
Fasken and Corbett, 2005; Saguez et al., 2005; Sommer and Nehrbass, 2005). The first level 
of quality control of mRNA biogenesis must take place in the nucleus. In this cellular 
compartment transcripts are made and matured and the ultimate goal of the nuclear quality 
control checkpoints is that only perfect mRNA molecules cross the NPC. Two locations are 
emerging as “hot spots” for quality control in the nucleus, the site of transcription and the 
nuclear periphery. The molecular mechanisms of these checkpoints are still poorly understood 
and much more data has been collected in yeast than in mammalian systems.  
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5.1 A nuclear turnover pathway for mRNA 
 
The first evidence for a quality control mechanism of gene expression operating in the 
nucleus came from experiments showing that pre-mRNA molecules bearing mutations that 
allow spliceosome assembly but impaired the splicing reaction were largely retained in this 
cellular compartment (Chang and Sharp, 1989; Legrain and Rosbash, 1989). Further 
experiments showed that mutated splicing reporter constructs were rapidly degraded in the 
nucleus of wild-type yeast cells (Burgess and Guthrie, 1993) and many yeast splicing mutants 
showed a strong reduction in mRNA levels without a corresponding accumulation of the 
unspliced precursor. These early observations suggested the existence of a nuclear turnover 
pathway to recognise and rapidly degrade unspliced pre-mRNA in yeast. The demonstration 
that such a pathway existed was finally reported in 2000 (Bousquet-Antonelli et al., 2000). 
This pathway involves a 3’ to 5’ degradation by a complex of exoribonucleases called the 
exosome and to a lesser extent also 5’ to 3’ degradation by the exoribonuclease Rat1p. The 
yeast exosome contains at least ten essential components, nine of which are 3’ to 5’ 
exoribonucleases and is active both in the nucleus and in the cytoplasm. The cytoplamic 
exosome participates in mRNA turnover. The nuclear exosome has additional components 
(Rrp6p, Rrp47p and Mtr4p) and was previously shown to be involved in the processing and 
degradation of small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and 
ribosomal RNAs (rRNAs) (Butler, 2002; Houseley et al., 2006). Mutation of nuclear exosome 
components in cells that are defective for splicing resulted in the nuclear accumulation of pre-
mRNA, suggesting a direct competition between the splicing machinery and the nuclear pre-
mRNA turnover pathway to degrade aberrant, unspliced transcripts (Bousquet-Antonelli et al., 
2000). Another evidence for the quality control function of the nuclear exosome came from 
the observation, in yeast, that deletion of the essential RRP6 (ribosomal RNA processing 6) 
gene (Briggs et al., 1998) could suppress a poly(A) polymerase mutant (pap1-1) revealing that 
Rrp6p was required for the degradation of transcripts with abnormal poly(A) tails (Burkard 
and Butler, 2000). It was also suggested that Rrp6p could be implicated in the decay of 
transcripts that do not acquire the correct complement of mRNA-binding proteins during their 
biogenesis (Zenklusen et al., 2002). Recent studies also showed that Rrp6p is required for the 
degradation of apparently normal mRNA that is retained in the nucleus through a pathway 
referred to as DRN (for decay of RNA in the nucleus). In addition to Rrp6p, the yeast DRN 
pathway depends on the 5’ to 3’ nuclear exoribonuclease Rat1p and on Cbc1p, a component 
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of the nuclear cap-binding complex (Das et al., 2003). It is not known whether the DRN 
pathway can also target abnormal transcripts and overlap with the exosome-mediated turnover 
pathway to degrade aberrant transcripts. It is conceivable to speculate that all transcripts that 
remain within the nucleus longer that they should are subject to a surveillance system and 
targeted for degradation (Kuai et al., 2005). The degradation could be mediated either by the 
DRN pathway if they are properly processed or by an exosome-mediated turnover pathway 
for aberrant transcripts (see Fasken and Corbett, 2005).  
The mRNA turnover pathways operating in the nucleus are still poorly characterised 
and most of the available data came from yeast. All the exosome subunits are conserved in 
humans, where the complex is known as PM/Scl particle, a target of autoimmune antibodies, 
but it is still not known if the human exosome fulfils all the roles that have been attributed to 
the yeast exosome (reviewed by Schilders et al., 2006).  
 
5.2 A polyadenylation-dependent checkpoint at the transcription site 
 
Several observations provided support for the view that mRNA 3’ end formation and 
mRNA export are mechanistically coupled events. Among these, one interesting observation 
was that yeast strains carrying lesions in several genes important for mRNA export produce 
nascent transcripts carrying poly(A) tails roughly 30 residues longer than the nascent poly(A) 
tails observed in wild-type cells (Hilleren and Parker, 2001). Moreover, analysis of the fate of 
the yeast heat shock transcripts SSA4 and HSP104 in a background of mRNA export mutants 
(rat7-1, mex67-5, and rat8-2 strains) confirmed the hyperadenylation phenotype and further 
showed that the specific transcripts were concentrated in a single intranuclear focus 
compatible with the site of transcription (Jensen et al., 2001b; Thomsen et al., 2003). This 
implies that polyadenylation and nuclear export are coupled in a step that involves the release 
of mRNA from the transcription site. Interestingly, unadenylated transcripts from the same 
genes, resulting from a pap1-1 mutant background, were also retained in the nucleus in 
discrete intranuclear foci compatible with transcription sites (Hilleren et al., 2001). The 
sequestration of both, unadenylated and hyperadenylated mRNAs, in transcription site foci 
indicated that a system exists in yeast to monitor the quality of 3’ end formation and inhibit 
the release of aberrant transcripts. Because defects in the nuclear exosome component Rrp6p 
partially rescued the temperature sensitivity of pap1-1 (Burkard and Butler, 2000), the effect 
of an RRP6 deletion on transcript localisation was investigated. In Rrp6p mutants both hypo- 
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as well as hyperadenylated mRNAs are released from the nuclear focus suggesting that Rrp6p 
and the nuclear exosome contributes to a checkpoint that monitors proper 3’ end formation of 
mRNA (Hilleren et al., 2001). It was also found that nuclear HSP104 transcripts produced in 
sub2, hpr1 and other THO complex mutant strains are either 3’ end truncated or retained at 
the transcription site in a Rrp6p-dependent manner (Libri et al., 2002). The localisation of the 
3’ end truncated transcripts is unclear and this phenotype can be reverted by deletion of RRP6 
which indicates that the 3’ end truncation results from incomplete nuclear degradation rather 
than from a failure to efficiently elongate them (Libri et al., 2002). Furthermore, a plasmid-
produced mRNA containing a self-cleaving hammerhead ribozyme element in place of 
cleavage and polyadenylation signals was shown to be predominantly unadenylated and 
exhibited a partial defect in export accumulating near its site of synthesis (Dower et al., 2004). 
In this case the nuclear accumulation of the transcripts was exosome-independent and could 
be relieved by insertion of a stretch of 48 or more DNA-encoded adenosine residues 
immediately upstream of the ribozyme element (a synthetic A tail). This indicates that, at least 
when the RNA is produced out of its normal chromatin context, a 3' stretch of adenosines can 
promote export, independently of cleavage and polyadenylation (Dower et al., 2004). A 
precise control of the poly(A) tail length seems to be important for mRNA release from sites 
of transcription. In yeast, three proteins were described to be important for the control of the 
poly(A) tail length in vivo, the poly(A) binding proteins Nab2p and Pab1p and the poly(A) 
nuclease, PAN (Dunn et al., 2005; Hector et al., 2002). Interestingly, loss of NAB2 
expression leads to hyperadenylation and nuclear accumulation of poly(A)+ RNA but, in 
contrast to mRNA export mutants, these defects can be uncoupled in a nab2 mutant strain 
(Hector et al., 2002). Pab1p contains a nonessential leucine-rich nuclear export signal and 
shuttles between the nucleus and the cytoplasm. It can exit the nucleus either as cargo of 
exportin 1 or bound to mRNA. Pab1p is essential but several bypass suppressors have been 
identified. Deletion of PAB1 from these bypass suppressor strains results in exosome-
dependent retention at sites of transcription (Dunn et al., 2005). Retention is also observed in 
cells lacking PAN. These nuclease complex is thought to be recruit by Pab1p and is 
responsible for trimming of the poly(A) tail to the length found on newly exported mRNAs 
(Dunn et al., 2005).  
Recently a complex called TRAMP (Trf4p/Air2p/Mtr4p polyadenylation complex) has 
been identified as an exosome activating complex (LaCava et al., 2005). In vitro, the TRAMP 
complex showed distributive RNA polyadenylation activity and is believed to ease exosome 
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access onto difficult substrates (e.g. highly structured ones) by adding an unstructured tag. 
TRAMP-assisted exosomal decay might subsequently occur through multiple rounds of 
adenylation/degradation (LaCava et al., 2005). It was recently shown that TRAMP complexes 
harbouring Trf4p are involved in nuclear mRNA quality control in S. cerevisiae (Rougemaille 
et al., 2007). However, in contrast to Rrp6p, Trf4p is not required for retention in nuclear foci 
of either the inducible HSP104 RNA or the constitutively expressed PDR5 RNA. 
Transcription pulse–chase experiments showed that HSP104 transcripts undergoing quality 
control in THO/sub2 mutant strains are partitioned into two different pools of molecules, one 
that undergoes rapid decay and another of stable RNAs retained in transcription site foci 
(Rougemaille et al., 2007).  
It is now clear that there is an Rrp6p-dependent retention at the transcription site of 
heat shock mRNAs produced in the context of mRNA export factor mutants as well as 
polyadenylation-malfunctioning mutants and strains deleted for Pab1p (Dunn et al., 2005; 
Hilleren et al., 2001; Libri et al., 2002). However, the mechanism for the exosome mediated 
detection and retention of the defective transcripts at the transcription site is still far from 
being completely understood.  
 
5.3 A final checkpoint at the nuclear periphery 
 
Recent work has uncovered a quality control checkpoint located at the nuclear face of 
the NPC that assures that only mature, fully processed mRNA molecules are exported from 
the nucleus (reviewed by Fasken and Corbett, 2005; Sommer and Nehrbass, 2005). The key 
players in this checkpoint are proteins localised in the inner basket of the NPC known as 
myosin-like proteins (Mlp1 and Mlp2) in S. cerevisae and as translocated promoter region 
(Tpr) protein in vertebrates. The first evidence that these proteins might be important for 
mRNP export came from the observation that overexpression of either Mlp1p or Tpr results in 
the accumulation of mRNA in the nucleus. Further studies showed that Mlp1p interact with 
the mRNP component Nab2p and suggested that it might act in a checkpoint at the nuclear 
pore by interacting with export-competent mRNPs (Green et al., 2003). In agreement with this 
suggestion it was demonstrated that Mlp1p is involved in the retention of unspliced mRNAs 
in the nucleus (Galy et al., 2004). Deletion of MLP1 allows unspliced transcripts to leak to the 
cytoplasm but has no effect on splicing. It was previously shown that proper retention on 
intron-containing mRNA molecules in the nucleus requires an intact 5’ splice site and 
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branchpoint (Legrain and Rosbash, 1989; Rain and Legrain, 1997). In agreement with this, an 
intact 5’ splice site was also shown to be required in the case of Mlp1-based retention of pre-
mRNA. The simplest explanation for this is that a factor that is dependent on this sequence 
for RNA binding is recognised by Mlp1p and serves as a marker of immature transcripts that 
should not be exported (Galy et al., 2004). Interestingly, the same authors identified an RNA-
dependent interaction between Mlp1p and the branchpoint binding protein SF1, which 
suggests an interaction between Mlp1p and the intron containing transcripts (Galy et al., 
2004). A recent paper adds further support for an important role of Mlp proteins in nuclear 
mRNA metabolism (Vinciguerra et al., 2005). This study shows that Mlp1p and Mlp2p retain 
intronless mRNP complexes produced in an Yra1 mutant background, that is, mRNPs with 
early assembly defects. More specifically, the loss of Mlp1p or Mlp2p increases the levels of 
transcripts that were reduced in Yra1 mutant strains and substantially rescues the growth 
defect of both Yra1 and Nab2 mutants but not of other mRNA export mutants. These results 
are consistent with a role of Yra1p and Nab2p in proper mRNP docking to Mlp proteins. This 
study also showed that mRNP complexes loaded with mutant Yra1p are sequestered on the 
Mlp platform and unable to proceed along the export pathway. This block negatively impacts 
on the expression of a subset of genes potentially located at the nuclear periphery 
(Vinciguerra et al., 2005). 
 
 
6. The human β–globin as a model to study quality control of gene 
expression 
 
Many of the most exciting discoveries in the field of eukaryotic gene expression are 
linked to globin research. The globin gene was the first gene to be cloned back in 1976, its 
promoter the first one to be extensively characterised in its constitutive elements and the so-
called locus control region (LCR) represented the first demonstration of the existence of 
distant regulatory elements controlling complex clusters of genes (for a review see Cao and 
Moi, 2002). NMD was the first reported example of a quality control mechanism of gene 
expression, and the beneficial effects of this surveillance mechanism in the phenotype of 
inherited human diseases started to be appreciated in the case of β-thalassemia (reviewed by 
Khajavi et al., 2006).  
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The diseases caused by mutations in the globin genes, known as hemoglobinopathies, 
are the most common and diverse group of genetically inherited disorders. The disease 
phenotypes can be divided into two categories. The structural hemoglobinopathies, that arise 
from amino acid substitutions in the globin chains that result in the production of 
haemoglobin with structural defects. The best known disorder of this category is sickle cell 
anemia. The second category is the thalassemias, which result from a reduction in the 
production of α-globin (α-thalassemia) or β-globin (β-thalassemia) proteins with a consequent 
reduction or total absence of haemoglobin (see Olivieri, 1999). The absence of defective 
globin chains in this group of diseases and therefore their recessive phenotype is a 
consequence of quality control mechanisms of gene expression that operate at the RNA level 
to avoid the translation of defective protein products (reviewed by Custódio and Carmo-
Fonseca, 2001).  
 
6.1 The human β-globin gene cluster and the LCR 
 
The human β-globin gene (HBB) cluster consists of five genes arranged in the short 
arm of chromosome 11 (region 11p15.5) in the same order in which they are expressed during 
development: 5'-ε-, Gγ -, Aγ-, δ-, and β-globin gene (Figure 8). The ε-globin gene is 
expressed during the first 6 weeks of embryonic life within the blood islands of the yolk sac; 
the two γ-globin genes are then expressed in the fetal liver throughout mid-pregnancy and 
start to decline just before birth. Finally, the adult β-globin gene begins to be expressed in the 
bone marrow around the time of birth (reviewed by Levings and Bungert, 2002; Li et al., 
2002). Transcription in the HBB cluster is under the control of a distal regulatory element 
known as locus control region (LCR) which is located up to 50 kb upstream of the β-globin 
gene. The LCR contain four erythroid specific DNase I hypersensitive sites (HS) and a further 
upstream site (HS-5) (Figure 8). HS are a hallmark of DNA-protein interactions and of an 
“open” chromatin structure that facilitates the access of regulators and lower the threshold for 
activation of the linked genes. The LCR was first identified by its ability to confer position-
independent, high level expression on a linked gene in the erythroid lineage of transgenic 
mice (Grosveld et al., 1987) and in erythroid cells in culture (Blom van Assendelft et al., 
1989; Talbot et al., 1989). The level of expression of a transgene in transgenic mouse lines or 
cloned cells is usually low and variable. It is believed that the levels of expression of 
transgenes are influenced by the site of integration and the surrounding chromatin and the 
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LCR abolishes this “position effects” allowing expression levels directly proportional to 
transgene copy number (Grosveld et al., 1987). An alternative interpretation for the observed 
low levels of expression of transgenes is that the insertion of multiple-copy arrays at single 
sites may result in condensation into heterochromatin and transcriptional inactivation (Garrick 
et al., 1998). In this context, the LCR may function to abolish heterochromatinisation of the 
array, therefore allowing expression levels directly proportional to transgene copy number. 
This hypothesis is supported by the study of LCR function at its endogenous location in cell 
lines suggesting that its primary role in this context is not the establishment and maintenance 
of an open β-globin chromatin domain, but rather to function in globin gene transcription 
activation (Epner et al., 1998; Reik et al., 1998). 
 
 
 
Figure 8 - The human β-globin gene locus (not drawn to scale). This locus consists of 5 
functional genes, indicated as dark boxes, arrayed in their order of developmental expression, 
5’-ε-Gγ-Aγ-δ-β-3’. There are 2 developmental switches in globin chain synthesis coincident 
with changes in site and type of erythropoiesis. During primitive erythropoiesis, the ε-globin 
gene is expressed in the embryonic yolk sac. The first switch occurs at approximately 8 weeks 
of gestation; the ε-globin gene is silenced and the Gγ- and Aγ-globin genes are expressed 
during definitive erythropoiesis in the fetal liver. The second switch occurs shortly after birth; 
the γ-globin genes are silenced and the β-globin gene and, to a lesser extent, the δ-globin gene 
are activated in the bone marrow. The locus control region (LCR) is represented as the sum of 
the five DNase I hypersensitive (HS) sites, indicated as white boxes. It should be noted that 
additional HS sites were mapped 5’ to HS-5, but it is currently not known whether these sites 
participate in globin gene regulation or whether they are associated with the regulation of 
genes located upstream of the globin locus. The HS core elements are 200-400 bp in size and 
separated from each other by more than 2 kb. Adapted from (Levings and Bungert, 2002). 
 
Several models have been proposed over the years to explain the LCR mode of action. 
Among them, the looping and tracking/scanning models are the most prevalent (Figure 9) 
(reviewed by Li et al., 2002). The looping model (Figure 9A) proposes that the LCR acts as 
an integral unit (a “holocomplex”) to interact directly with individual globin genes by looping 
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through the nucleoplasm and stimulating their transcription (Bungert et al., 1995; Choi and 
Engel, 1988; Wijgerde et al., 1995). This model can explain the balanced competition 
between the genes and the LCR for function (reviewed by Grosveld et al., 1998), the fact that 
the LCR can activate only one gene at a time and the flip-flop transcription observed in the β-
globin locus (Wijgerde et al., 1995). This flip-flop was observed using in situ hybridisation 
that allowed the detection of primary γ-globin transcripts in the nucleus of individual 
embryonic cells that had already switched and display predominantly β-globin chain in the 
cytoplasm. This experimental evidence indicates that the LCR can flip-flop back and forth to 
activate adjacent genes such as the γ- and β-globin genes and that it is the total time spent by 
the LCR in each gene interaction that determines the prevailing chain in the cytoplasm 
(Wijgerde et al., 1995). Further support for this model came from the observations that HS of 
the LCR are in close physical proximity to an actively transcribed β-globin gene located over 
50 kb away in vivo (Carter et al., 2002; Tolhuis et al., 2002). However, this model has not 
provided a mechanism to explain some aberrant transcripts detected across the LCR and 
intergenic regions in erythroid cells (Ashe et al., 1997). In the tracking or scanning model 
(Figure 9B), erythroid-specific and ubiquitous transcription factors and cofactors bind 
recognition sequences in the LCR, forming an activation complex that migrates, or tracks, 
linearly along the DNA helix of the locus (Blackwood and Kadonaga, 1998; Tuan et al., 
1992). When this transcription complex encounters the basal transcription machinery located 
at the correct promoter (according to the developmental stage), the complete transcriptional 
apparatus is assembled and transcription of that gene is initiated. This model can explain the 
intergenic transcription that could function to deliver transcription complex proteins to the 
globin gene promoters via the tracking mechanism. A facilitated-tracking model that 
incorporates aspects of both the looping and tracking models was also proposed (Figure 9C) 
(Blackwood and Kadonaga, 1998). According to this hybrid model the LCR bound to 
transcription factor and coactivators loops to contact downstream DNA in promoter-distal 
regions, where the transcription factor complex is released. This complex then tracks in small 
steps along the chromatin until it encounters the appropriate promoter with its associated 
bound proteins, a stable loop structure is established and gene expression proceeds. 
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Figure 9 - Models of LCR function. Transcription factors are shown as ovals and circles. 
The flanking DNA sequences of the HSs are depicted as loops between the HS cores. (A) 
Looping model. Transcription factors bind to the LCR HSs and the gene promoter. The LCR 
directly interacts with the gene promoter by looping out the intervening DNA, thus forming 
an active transcription complex at the gene promoter. (B) Tracking or scanning model. 
Sequence-specific transcription factors bind to the LCR, forming a complex that tracks down 
the DNA sequence, as depicted by the large white arrow, until encountering transcription 
factors bound to the appropriate gene promoter, initiating high-level gene expression. (C) 
Facilitated tracking model. Aspects of both looping and tracking models are combined. 
Sequence-specific transcription factors bind the LCR, looping then occurs to deliver the 
bound transcription factors proximal to the gene promoter, followed by tracking, until they 
encounter transcription factors bound to the appropriate gene promoter. Adapted from (Li et 
al., 2002). 
 
6.2 The LCR/MEL expression system 
 
Since the discovery of the LCR, a great number of HS dissections and combinations 
have been done in different experimental systems to identify the minimal sequence 
requirements to create an LCR compact enough to fit available vectors for the gene therapy of 
the thalassemias and sickle cell disease. During the course of this line of research a shorter 
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version of the LCR (with only 6.5 kb instead of the normal 20 kb) has been engineered 
containing sequences from the HS sites 1-4. This micro-locus control region (βLCR) was 
shown to replace the role of the LCR in transgene expression (Collis et al., 1990). Eukaryotic 
expression vectors where developed taking advantage of this βLCR, in which the gene of 
interest is placed under the control of the HBB promoter and cloned downstream of the βLCR. 
Stable transfection of these vectors in erythroid cells (because the globin LCR is erythroid 
specific) has allowed high levels of expression of transgenes which are directly proportional 
to the transgene copy number (Needham et al., 1992). This makes possible quantitative 
comparisons for example between wild-type genes and those carrying different mutations. 
The type of erythroid cells that has been extensively used as an expression system with 
this kind of vectors are the murine erythroleukaemia (MEL) cells. MEL cells are murine 
virus-transformed spleen hematopoietic cells, which grow in suspension culture. These 
progenitor cells, arrested at the pro-erythroblast stage of differentiation, can be induced in 
culture with various chemical agents to undergo terminal erythroid differentiation. MEL cells 
committed to the erythroid differentiation programme go through a series of morphological 
and biochemical alterations that resemble those seen in the differentiation of normal early 
erythroid progenitors. These include transcriptional activation of several genes related to the 
erythroid phenotype and selective repression of many others, progressive changes in cell 
surface architecture, condensation of nucleus, reduction of cell size and even nuclear 
extrusion under certain culture conditions (for an extensive review see Tsiftsoglou et al., 
2003). Among the genes exclusively related to the erythroid phenotype, whose expression is 
induced upon differentiation, are the murine globin genes (α-globin, βmajor-globin and βminor-
globin), resulting in very high levels of haemoglobin in the cytoplasm that give a pink-red 
colour to the differentiated cell pellets. In MEL cells transfected with βLCR expression 
vectors the expression of the transgenes under the control of the βLCR parallel the expression 
of the endogenous murine globin genes.  
 
6.3 Using the LCR/MEL expression system to study quality control of gene 
expression in the nucleus 
 
HBB genes defective in some aspects of pre-mRNA processing have been expressed 
under the control of βLCR in MEL cells (Antoniou, 1991). This type of research initially 
demonstrated that the larger, second intron of HBB is absolutely required for the accumulation 
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of cytoplasmic mRNA (Collis et al., 1990). Transgenes lacking this intron give rise to nuclear 
localised transcripts which are not correctly 3’ end cleaved (Antoniou et al., 1998). The 
expression of an HBB gene with a mutated 5’ splice site at the second intron results in very 
low levels of β-globin mRNA in the cytoplasm, a phenotype identical to that seen in β-
thalassemia patients harbouring similar mutations (Antoniou et al., 1998). Given this initial 
observation that HBB transcripts defective in either splicing or 3’ end cleavage were not 
detected in high levels in the cytoplasm of MEL cells, we hypothesised that some kind of 
quality control mechanism linked to the processing of the primary transcripts should be 
operating in the nucleus. The βLCR expression system in MEL cells offered us great potential 
to explore this hypothesis in an in vivo context. The high level of gene expression afforded by 
the βLCR in this system made it easier to develop an in situ hybridisation approach to study 
the nuclear localisation of both wild-type and processing defective mutant transcripts to start 
to explore the quality control mechanisms of gene expression in the mammalian cell nucleus. 
 
 
7. Goals of the work 
 
The main goal of this work was to elucidate the quality control mechanism responsible 
for the retention within the nucleus of human β-globin transcripts with mutations that 
impaired their processing. To reach this goal we proposed to: 
 
1- Determine the intranuclear localisation of the retained transcripts. 
 
2- Identify the molecular players responsible for the retention. 
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Results 
1. Inefficient processing impairs release of RNA from the site of 
transcription 
 
Initial biochemical studies have shown that human β-globin (HBB) transcripts with 
mutations that impaired their processing were underrepresented in the cytoplasm of MEL 
cells and enriched in the nuclear fraction, a phenotype identical to that seen in β-thalassemia 
patients harbouring similar mutations (Antoniou et al., 1998). This result was consistent with 
the retention in the nucleus of incorrectly processed transcripts. Based on this initial 
observation, we hypothesised the existence in the mammalian nucleus of a quality control 
mechanism to retain the incorrectly processed transcripts. To elucidate the mechanism 
responsible for the observed retention the first goal was to determine the intranuclear 
localisation of the retained transcripts. To address this, our experimental approach was based 
on the direct visualisation of both normal and mutated HBB transcripts using fluorescence in 
situ hybridization and confocal microscopy. The principal conclusion from this part of the 
work was that the intranuclear retention of the abnormally processed transcripts was taking 
place in close proximity to the site of transcription.  
 
 
 
 
 
 
 
Work published in: The EMBO Journal Vol.18 No.10 pp.2855-2866, 1999 
 
I would like to stress that some of the results presented and discussed in this section are 
the product of collaborative work. Dr. Michael Antoniou, Dr. Finola Geraghty and Dr. Frank 
Grosveld were responsible for the generation of MEL cell clones analysed in this work. The 
statistical analysis of the results was performed by Dr. H. Sofia Pereira. 
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2. In vivo recruitment of exon junction complex proteins to 
transcription sites in mammalian cell nuclei 
 
Having localised the retention of the abnormally processed HBB transcripts to the site 
of transcription, indicating that the quality control mechanism was probably co-
transcriptional, the next step was to determine the molecular players involved in this 
mechanism. The retention could be directly mediated by proteins that were bound to the 
nascent transcripts and were stalled due to the incomplete processing or could be due to the 
absence of recruitment of proteins essential for the release and/or transport of the transcripts 
from the gene locus. To test the later hypothesis we decided to study the recruitment of exon 
junction complex (EJC) proteins and mRNA export factors to the retention sites in the 
nucleus. From this work we concluded that EJC proteins were recruited in vivo to sites of 
normal HBB transcription but not to the mutant HBB transcription sites. These results suggest 
that EJC proteins bind stably to the pre-mRNA co-transcriptionally and the accumulation of 
EJC proteins at the transcription sites requires efficient processing. No concentration of the 
export factors NXF1/TAP, p15 was detected on nascent transcripts, arguing that in 
mammalian cells these proteins bind the mRNA shortly before or after release from the sites 
of transcription 
 
 
 
 
 
Work published in: RNA Vol.10 No.4 pp.622-633, 2004 
 
I would like to stress that the results presented and discussed in this section were 
equally obtained by me and Dr. Célia Carvalho. I contributed with all the results produced 
using as a model system the murine erythroleukemia (MEL) cells stably transfected with the 
human β-globin gene and Dr. Célia Carvalho contributed with the results produced using 
HeLa cells infected with adenovirus. Inês Condado participated in some FISH experiments, 
Dr. Michael Antoniou generated the MEL cell clones analysed and Dr. Benjamin Blencowe 
gave a valuable contribution in the RNase protection assay. 
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3. Splicing- and cleavage-independent requirement of RNA 
polymerase II CTD for mRNA release from the transcription site 
 
One hypothesis to explain the retention of the pre-mRNA processing mutants at the 
transcription site was that the transcripts could be retained via the CTD of RNA Pol II. The 
big clue for this hypothesis came from reports showing that both splicing and 3’ end 
processing factors could associate with the CTD of RNA Pol II. Since the processing mutants 
analysed were still able to assemble some processing machinery, the release of the transcripts 
could be blocked by the stalled or abnormal processing machinery associated with the CTD. 
In order to test this hypothesis we generated cell lines that express either the wild-type HBB 
gene or a mutant version defective in splicing and an α-amanitin resistant form of RNA Pol II 
LS with either 52 (wt), 31 (Δ31) or 5 (Δ5) repeats of the CTD. Surprisingly, the principal 
finding from this study was that wild-type HBB transcripts made by RNA Pol II with only 31 
CTD repearts were retained at the site of transcription. We showed that the retained 
transcripts were correctly processed providing evidence that mRNA release from the 
transcription site requires the heptad repeat structure of the CTD. Based on this results we 
proposed that the missing heptads in the truncated CTD mutant were required for binding of 
proteins implicated in a final co-transcriptional maturation of spliced and 3’ end cleaved 
mRNAs into export-competent ribonucleoprotein particles. 
 
 
 
 
 
 
 
Work published in: J.Cell Biol. Vol.179 No.2 pp.199-207, 2007 
 
I would like to stress that some of the results presented and discussed in this section are 
the product of collaborative work. Dr. Michael Antoniou gave a valuable contribution in the 
generation of the murine erythroleukemia (MEL) clones stably transfected with the α-
amanitin resistant form of the RNA polymerase II largest subunit and Dr. Maria Vivo 
participated in the FISH analysis of the clones. 
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4. Abundance of the largest subunit of RNA polymerase II in the 
nucleus is regulated by nucleo-cytoplasmic shuttling 
 
To test the hypothesis that the transcription site retention of HBB pre-mRNA 
processing mutants could be mediated by the CTD of the largest subunit of RNA Pol II we 
established murine cell clones that express a α-amanitin resistant form of this subunit. The 
cell lines generated were screened for survival and the ability to transcribe in the presence of 
α-amanitin. Two cell lines that pass this screening process were chosen for further 
characterisation, one with low levels of expression of the exogenous RNA Pol II LS and 
another one with very high expression levels of this subunit. These cell lines were used as a 
model to study the sub-cellular localisation of the largest subunit of RNA Pol II. From this 
study we concluded that the over-expressed RNA Pol II LS is predominantly 
hypophosphorylated, soluble and accumulates in the cytoplasm in a CRM1-dependent 
manner. In contrast the transcriptionally active form of RNA Pol II LS (containing 
phosphoserine in position 2 of the CTD repeats) is restricted to the nucleus and its levels 
remain remarkably constant, even in the cell line with very high expression levels of this 
subunit. These results suggest that the nuclear-cytoplasmic distribution of RNA Pol II LS may 
be regulated by shuttling and we propose that this may provide a mechanism to control the 
pool of RNA polymerase subunits that is accessible for assembly of a functional enzyme in 
the nucleus.  
 
 
 
 
 
 
Work published in: Exp. Cell Res. Vol.312 No.13 pp.2557-2567, 2006 
 
Concerning this part of the work I would like to stress that Dr. Michael Antoniou gave a 
valuable contribution in the generation of the clones stably transfected with the α-amanitin 
resistant form of the RNA polymerase II largest subunit. 
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Concluding Remarks and Future Perspectives 
Mechanisms must exist in the nucleus to proofread the transcripts and to ensure that 
only fully processed transcripts reach the translation machinery in the cytoplasm. The main 
goal of this work was to elucidate the quality control mechanism responsible for the nuclear 
retention of human β-globin transcripts with mutations that impaired their processing. The 
system we have exploited in these studies consists of wild-type and processing mutant 
versions of the human β-globin gene stably transfected into murine erythroleukemia (MEL) 
cells, under the control of the locus control region (LCR). The principal discovery of this 
study was the demonstration that pre-mRNA mutants unable to be exported to the cytoplasm 
due to the inability to undergo splicing or 3’ end processing are retained within the nucleus in 
close proximity to the site of transcription. This observation imply that efficient pre-mRNA 
processing is crucial and therefore rate limiting for the release of transcripts from the site of 
transcription. We showed that exon junction complex (EJC) proteins co-localise with protein 
components of the spliceosome at the transcription sites in the nucleoplasm, providing in vivo 
evidence that the EJC binds co-transcriptionally to mRNPs. In contrast, mutant β-globin pre-
mRNAs that are neither spliced nor released from the site of transcription fail to recruit 
spliceosome snRNPs and EJC proteins. This suggests that splicing of β-globin pre-mRNA is 
required for efficient recruitment of the EJC and subsequent targeting of the resulting mRNP 
to the nuclear export pathway. A major player in co-transcriptional pre-mRNA maturation is 
the carboxyl-terminal domain (CTD) of the largest subunit of RNA Polymerase II (RNA Pol 
II LS) which acts by facilitating specific interactions between processing factors while the 
transcript is still attached to the polymerase (reviewed in Bentley, 2005). We generated MEL 
cell lines that express α-amanitin resistant RNA Pol II LS with either full-length or truncated 
forms of the CTD to investigate the role of the CTD in transcript release. The results revealed 
that deleting 21 C-terminal heptads of the CTD causes human β-globin mRNA retention at the 
site of transcription but without inhibiting splicing or 3’ end formation. This implies a novel 
and previously unsuspected involvement of the CTD in mRNP maturation events that occur 
after splicing, cleavage and polyadenylation have taken place. 
 
Transcription site retention of pre-mRNA processing mutants 
The finding that both splicing and polyadenylation factors can associate with CTD of 
RNA Pol II (Du and Warren, 1997; McCracken et al., 1997b; Mortillaro et al., 1996; Yuryev 
et al., 1996) let to the hypothesis that RNA processing mutants may be retained close to the 
DNA template by remaining tethered to a stalled or abnormal processing machinery 
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associated with the CTD of the polymerase. The range of pre-mRNA mutants we have 
analysed suggests that assembly of the processing machinery for both splicing and 3’ end 
formation is involved in the retention mechanism. A prediction of the model in which both the 
splicing and the 3’ end processing machinery is associated with the CTD of RNA Pol II is 
that, a normal mRNA would be released from the CTD as it is processed, whereas a pre-
mRNA processing mutant would remain bound to the processing machinery and therefore to 
the CTD (Figure 10). As a consequence RNA Pol II would not be released from the mutant 
gene upon transcription termination, which would result in the stalling of oncoming RNA Pol 
II molecules on the template and therefore in the reduction of the overall rate of transcription.  
 
 
 
Figure 10 - A model for processing-dependent mRNA release from the transcription site 
(A) Both splicing and 3’ end processing factors associate with the CTD of RNA Pol II and a 
fully processed mRNA is released from the CTD after completion of splicing and 3’ end 
processing. Human β-globin transcripts harbouring mutations that impair splicing (B) or 3’ 
end processing (C) are retained near the site of transcription, presumably stalled by the 
processing machinery tethered to the CTD.  
 
Furthermore, if pre-mRNA processing mutant transcripts fail to be released from the site of 
transcription they should accumulate to a significantly higher amount at the site of 
transcription when compared to the transcripts of the wild-type human β-globin gene and this 
should result in an increase in the intensity of the nuclear foci produced by in situ 
hybridisation. However, a careful examination of the wild-type MELβWT and 5' splice site 
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mutant MELβSM cells that harbour a similar transgene copy number showed that there is no 
increase in signal intensity. In fact, nuclear foci of the βSM transcripts are frequently smaller 
and less intense than the βWT foci. This result is consistent with the hypothesis that mutated 
transcripts are stalled on the template with a concurrent feedback mechanism to the 
transcription machinery.  
To test this hypothesis, the effect of this splicing mutation on transcription should be 
carefully analysed. This could be achieved comparing the density of transcribing RNA Pol II 
along the βWT and βSM transcription units using a nuclear run-on assay. Chromatin 
immunoprecipitation (ChIP) assays with antibodies that recognise the different 
phosphorylation forms of the CTD could also be used to compare the evolution of CTD 
phosphorylation along the βWT and βSM transcription units. This experiment could give 
valuable information into the dynamics of the human β-globin transcription cycle because it is 
well established that the CTD is dynamically phosphorylated during each transcription cycle. 
Five out of the seven residues of the CTD heptapeptides can be phosphorylated, but residues 
Ser2 and Ser5 are the main targets of phosphorylation (Bensaude et al., 1999; West and 
Corden, 1995). When RNA Pol II is recruited to a promoter the CTD is hypophosphorylated 
(recognised by 8WG16 antibody) and becomes hyperphosphorylated during transcription 
elongation (Kim and Dahmus, 1986). Phosphorylation of Ser5 residues (recognised by H14 
antibody) occurs at or near the promoter, while Ser2 residues (recognised by H5 antibody) are 
phosphorylated during the transition to the elongation phase of transcription as the 
polymerases move away from the promoter (Chesnut et al., 1992; Komarnitsky et al., 2000; 
Lu et al., 1991). CTD phosphorylated on Ser2 residues is considered a marker of efficiently 
transcribing or elongating RNA Pol II (Palancade and Bensaude, 2003). Therefore 
comparison of ChIP results obtained with H5 antibody on MELβWT and mutant MELβSM 
cells could indicate if the splicing mutation has an effect on transcription, specifically in the 
transition from the initiation to the elongation phase.  
 
The site of transcription: a hot spot for quality control 
Current evidence suggests that any failure in pre-mRNA processing compromising the 
integrity of an mRNA may cause its retention in the nucleus at the site of transcription 
(reviewed in Jensen et al., 2003). Why is such a surveillance mechanism operating at the site 
of transcription? There is evidence that pre-mRNA processing is a co-transcriptional event 
and that the different steps in pre-mRNA processing are all interconnected (reviewed by 
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Bentley, 1999). Most likely, this cross-talk between the distinct processing steps during 
mRNA maturation plays a critical role to guarantee the quality of the final messenger, 
ensuring that only correctly processed transcripts leave the site of transcription.  
Efficient 5’ capping enhances both splicing of the first intron and 3’ end processing, 
while 3’ end cleavage requires splicing of the terminal intron and splicing of the last intron 
depends on the recognition of the poly(A) site (see Fong and Zhou, 2001). The presence of an 
intact poly(A) signal is also crucial for transcription termination, i.e. release of the RNA 
transcript from the polymerase and dissociation of the polymerase from the DNA template 
(Osheim et al., 1999). This constitutes an additional quality checkpoint ensuring that 
transcription does not terminate until RNA Pol II has moved past the end of the entire mRNA 
sequence. In fact, transcription termination has been shown to occur hundreds of kilobases 
past the poly(A) site (Bauren et al., 1998; Dye and Proudfoot, 1999; Osheim et al., 1999). 
Cleavage at the poly(A) site occurs at the same time as or just before transcription termination 
(Dye and Proudfoot, 1999). Termination additionally requires the presence of a transcriptional 
pause site in the DNA (Yonaha and Proudfoot, 2000). This pause may be necessary for the 
interaction of the CTD-associated processing factors with the pre-mRNA, which may then 
trigger the cleavage reaction at the 3’ end and promote the release of the polymerase from the 
DNA template (Dye and Proudfoot, 1999).  
Analysis of the human β-globin gene indicated that transcription termination is 
preceded by multiple cleavage reactions in the co-transcriptional cleavage (CoTC) site 
downstream of the poly(A) site. The occurrence of such pre-termination cleavage reactions, 
appears to be essential for effective release of the nascent transcript from the DNA template 
(Dye and Proudfoot, 2001). The RNA sequence at the CoTC forms a ribozyme and mutations 
that inhibit self cleavage at the CoTC site also inhibit transcriptional termination (Teixeira et 
al., 2004). According to these data, the nascent transcript probably maintains an indirect 
interaction with the CTD during co-transcriptional cleavage, until the final cleavage and 
polyadenylation reaction triggers both the release of the transcript from the CTD and the 
dissociation of RNA Pol II from the template  
The time lag between transcription of the poly(A) site and the final cleavage reaction 
that precedes polyadenylation may have important functional implications. In fact, by 
allowing the completion of all the processing reactions before termination, this delay may be 
crucial for the final check on the integrity of the transcript before cleavage occurs. Consistent 
with this view, a mutation in the 3’ splice site of the terminal intron of human β-globin 
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abolishes transcriptional termination (Dye and Proudfoot, 1999). Since efficient splicing of 
the last intron of β-globin is essential for proper cleavage (Antoniou et al., 1998; Dye and 
Proudfoot, 1999), the effect of this splicing mutation on transcript termination may be a 
consequence of its interference with 3’ end cleavage. Nevertheless, transcription termination 
appears to constitute the final trigger for the release of a fully processed mRNA from the site 
of transcription and failure of any of the pre-mRNA processing reactions may impair this final 
step, therefore retaining the transcripts at the gene locus. The β-globin 5' splice site mutant 
βSM we have analysed is 3’ end cleaved at normal rates (Antoniou et al., 1998). It remains to 
be determined if transcription termination may also be impaired in this mutant and if this is 
contributing for its retention at the site of transcription. We have also shown that the CTD is 
important for transcription site release independently of its role in promoting splicing and 3’ 
end processing. It would also be important to determine if the CTD has a role in transcription 
termination. Interestingly, it was shown in S. cerevisiae that Pcf11, a component of the 
cleavage factor IA (CFIA), associates directly with both RNA and the CTD and is able to 
dismantle the elongating complex in vitro (Zhang et al., 2005). In Drosophila this protein 
(dPcf11) is also directly involved in termination (Zhang and Gilmour, 2006). dPcf11 is 
concentrated at the 3' end of the hsp70 gene, and depletion of dPcf11 with RNAi causes RNA 
Pol II to readthrough the normal region of termination. Biochemical analysis revealed that 
dPcf11 forms a bridge between the CTD and the RNA and dismantles the elongation 
complexes by a CTD-dependent mechanism (Zhang and Gilmour, 2006). Human Pcf11 
(hPcf11) is a component of cleavage factor II (CFII), which is required for pre-mRNA 
cleavage during 3’ end processing (de Vries et al., 2000). However, functions of hPcf11 in 
RNA Pol II termination have only recently started to be explored. It was shown that it causes 
premature termination on an HIV provirus (Zhang et al., 2007) and depletion of hPcf11 in 
HeLa cells reduces the efficiency of transcriptional termination on transfected constructs and 
stabilizes the 3’ products of RNA cleavage at or beyond the poly(A) signal (West and 
Proudfoot, 2007). 
 In the yeast S. cerevisiae, several types of defective mRNAs also accumulate at or near 
the site of transcription (reviewed in Saguez et al., 2005). In all cases of transcription site 
retention in yeast the Rrp6 protein as well as other components of the nuclear exosome are 
required, suggesting that this complex is part of a quality control checkpoint that monitors for 
correct processing of pre-mRNA (Dunn et al., 2005; Hilleren et al., 2001; Jensen et al., 2001b; 
Libri et al., 2002). The exosome is a complex of 3’ to 5’ exoribonucleases composed of ten 
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core subunits and the Rrp6 protein which is required for its nuclear activity (reviewed in 
Vanacova and Stefl, 2007). There is evidence in Drosophila that the exosome is recruited to 
active genes via interactions with elongation factors (Andrulis et al., 2002). The human 
counterpart of the yeast exosome is the polymyositis-scleroderma (PM/Scl) complex and the 
protein PM/Scl-100 the orthologue of Rrp6p. However, a role for PM/Scl-100 in 
transcription-site retention has not been described. We have shown that the protein PM/Scl-
100 is recruited in vivo to the site of human β-globin transcription, both when it is transcribed 
by an RNA Pol II LS with wild-type CTD and when transcription occurs exclusively by an 
RNA Pol II LS with 31 repeats in the CTD which results in transcription-site retention. It will 
be important to determine if in mammals transcription site retention of processing defective 
mutants also occurs in the absence of a functional nuclear exosome.  
 
Formation of an export competent mRNP particle 
During processing, nascent mRNA molecules assemble together with RNA binding 
proteins into ribonucleoprotein particles (mRNPs; Aguilera, 2005; Moore, 2005). Once 
released from the gene template, mRNP particles must reach the nuclear pore in order to be 
translocated to the cytoplasm. It is currently believed that after disengaging from the 
transcription and processing machinery mRNPs move by random Brownian motion 
throughout the nucleoplasm (reviewed by Gorski et al., 2006). As diffusion cannot be 
regulated, traffic control of mRNP molecules must rely on retention at specific locations 
within the nucleus (Gorski et al., 2006). According to the current view these locations are the 
site of transcription (reviewed in Jensen et al., 2003) and, at least in yeast, the nuclear pore 
(Galy et al., 2004). 
The commitment of a transcript for export from the nucleus involves the binding of 
several RNA binding proteins that include shuttling hnRNPs, EJC proteins and export factors. 
Translocation of mRNPs through the nuclear pore complex requires binding of an 
heterodimer composed of NXF1 (or TAP) and NXT1 (or p15) (Mex67 and Mtr2 in 
S.cerevisiae). NXF1, which interacts both with RNA binding adapter proteins and 
components of the nuclear pore complex, is believed to be the major receptor for the export of 
mRNA molecules to the cytoplasm (Izaurralde, 2002; Lei and Silver, 2002b; Reed and Hurt, 
2002). The EJC protein REF1/Aly has been identified as a factor that facilitates the nuclear 
export of mRNA by interacting with the export receptor NXF1 (Rodrigues et al., 2001; Stutz 
et al., 2000; Zhou et al., 2000). REF1/Aly is recruited to spliced mRNAs through physical 
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interactions with UAP56 (Luo et al., 2001; Strasser and Hurt, 2001), a putative RNA helicase 
also implicated as a splicing factor required for early spliceosome assembly (Libri et al., 
2001; Zhang and Green, 2001). Contrasting with NXF1 and UAP56, the depletion of which 
causes nuclear accumulation of mRNA, the EJC proteins REF/Aly, RNPS1, SRm160, and 
Y14 are dispensable for bulk mRNA export (Gatfield and Izaurralde, 2002; Longman et al., 
2003; MacMorris et al., 2003). Accordingly, SR proteins have been proposed as adaptors that 
in addition to REF1/Aly can mediate the interaction between NXF1 and cellular mRNAs 
(Huang et al., 2003; Huang and Steitz, 2001; Huang et al., 2004). Interestingly, SR proteins 
have recently been shown to specifically associate with RNA Pol II and function in coupling 
transcription to splicing (Das et al., 2007). 
Since the formation of an export-competent mRNP particle involves the binding of 
several proteins to the nascent transcripts and the protein composition changes as the 
transcripts are being processed it is possible that these proteins are a key component in the 
quality control mechanism that prevents the abnormal transcripts from reaching the 
cytoplasm. These proteins could prevent the release of incorrectly processed transcripts from 
specific locations and/or promote the export of the correct ones by the addition of an “export 
licence” that may be important for the translocation step at the nuclear pore complex. In this 
context one hypothesis to explain the retention human β-globin processing mutants at the 
transcription site could be the absence of recruitment of proteins essential for the release 
and/or transport of the transcripts from the gene locus. We studied the recruitment of EJC 
proteins and mRNA export factors to human β-globin transcription sites and found that 
several EJC proteins co-localise with protein components of the spliceosome at sites of 
transcription and splicing in the nucleoplasm, providing in vivo evidence that the EJC binds 
co-transcriptionally to mRNPs. No accumulation of the export factors NXF1 and NXT1 was 
detected at the transcription sites, arguing that in mammalian cells these proteins are recruited 
at a later stage in the export pathway probably shortly before or after release from the gene 
template. In agreement with this result it was reported that NXF1 binds very weakly to 
purified spliced mRNPs in vitro (Zhou et al., 2000). Contrasting with the results obtained for 
wild-type human β-globin transcripts, mutant pre-mRNAs defective in splicing and 3’ end 
processing do not recruit spliceosome snRNPs or the EJC proteins SRm160, REF and 
UAP56. Although these results suggest that splicing of β-globin pre-mRNAs is required for 
efficient recruitment of the EJC and subsequent targeting of the resulting mRNP to the 
nuclear export pathway further studies are required to determine if these proteins are involved 
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in transcription site release. One possibility to address this would be to artificially target EJC 
proteins and/or export factors to the retained processing mutants and ask which protein could 
induce the release of the transcripts.  
 
CTD dependent mRNA release from the site of transcription 
The CTD of RNA Pol II LS is composed of heptapeptide repeats with the consensus 
YSPTSPS (Corden et al., 1985), and the number of repeats varies from 26 in yeast to 40 in 
Drosophila and 52 in mammals (Allison et al., 1985; Corden et al., 1985). Not only has the 
number of repeats increased through evolution but also the number of repeats that deviates 
from the consensus sequence (Stiller and Hall, 2002). In mammals there are 31 non-consensus 
repeats and most of them are located at the C-terminus. After repeat 52 the mammalian CTD 
further comprises a specific 10 amino acid motif. It has been speculated that the evolution of 
longer CTDs with non-consensus repeats could have resulted in the attribution of specific 
functions to different regions of the CTD (Fong and Bentley, 2001). Accordingly, CTD 
deletion analysis has shown that heptad repeats 1-15 or 1-25 support capping but not splicing 
or 3’ end formation, whereas heptads 27-52 plus the C-terminal 10 residues can support 
efficient capping, splicing and 3’ end formation (Fong and Bentley, 2001). More recent 
studies have demonstrated that mutation of the terminal 10 amino acid motif of the CTD 
inhibited splicing, 3’ end cleavage (Fong et al., 2003) and RNA release from the site of 
transcription (Bird et al., 2005). Based on these observations it was proposed that the CTD is 
required for transcript release as a consequence of its role in splicing and 3’ end cleavage 
(Bird et al., 2005). However, we have show that a partial truncation of the CTD (Δ31) 
containing heptads 1-23, 36-38 and 48-52 including the terminal 10 amino acid motif is 
sufficient to support transcription, splicing, 3’ end cleavage and polyadenylation, but the 
mRNA fails to be efficiently released from the site of transcription. These novel observations 
imply that the CTD is involved in processes that control the release of transcripts by a 
mechanism independent from splicing and cleavage.  
 An important player acting at the interface between transcription and biogenesis of 
export-competent mRNPs is the TREX complex. This complex, initially characterised in 
yeast is formed by the THO (a four-protein complex involved in transcription elongation and 
the maintenance of genome stability) (Chávez et al., 2000), Sub2p and Yra1p (Strasser et al., 
2002). Null mutations of any component of THO lead to impairment of transcription and 
RNA export defects (Chávez et al., 2000; Rondón et al., 2003; Schneiter et al., 1999; Strasser 
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et al., 2002). Mutations of Sub2 and Yra1 confer similar transcription-impairment phenotypes 
as THO mutations (Fan et al., 2001; Jimeno et al., 2002; Rondón et al., 2003). Recently, the 
human TREX complex was characterised in detail and shown to contain the EJC proteins 
REF1/Aly, UAP56 and the human counterpart of the THO complex (Masuda et al., 2005). In 
vitro studies indicate that the human THO complex associates with spliced mRNA but not 
with unspliced pre-mRNA and this association is independent of transcription (Masuda et al., 
2005). Whether the TREX complex participates in release of mRNA from the site of 
transcription is unknown. We showed that the EJC proteins REF1/Aly and SRm160 are 
recruited to human β-globin transcripts made by the RNA Pol II with the Δ31 CTD, that 
remain at the transcription site after transcriptional inhibition, indicating that the deposition of 
the EJC onto spliced mRNA is not sufficient for its release. 
Several lines of evidence argue that 3’ end formation by cleavage and polyadenylation 
is important for mRNA export. Nevertheless, artificial 3’ end cleavage by a self-cleaving 
ribozyme is not sufficient to permit mRNA export (Eckner et al., 1991; Huang and 
Carmichael, 1996; Libri et al., 2002). Moreover, accumulation of ribozyme-cleaved RNA 
near its site of transcription was rescued by a synthetic A-tail (a stretch of DNA-encoded 
adenosine residues) in the absence of factors required for normal cleavage and 
polyadenylation, suggesting that mRNA release may be mediated by proteins that bind to 
poly(A)+ RNA such as Pab1p and Nab2p (Dower et al., 2004). Indeed, Nab2p has been 
implicated in 3’ end formation and yeast strains defective for Nab2p function accumulate 
hyperadenylated RNA in the nucleus (Hector et al., 2002) similarly to what is observed in 
mutants for general mRNA export factors (Hilleren et al., 2001; Jensen et al., 2001b). 
Although no direct and prominent role for yeast Pab1p or mammalian PABPN1 in mRNA 
export has yet been demonstrated, Pab1p overexpression rescued the export defect of the 
Nab2p-defective strain further suggesting that Pab1p may promote export or remove retention 
factors (Dower et al., 2004). Thus, one possibility is that the CTD plays a role in recruiting 
polyadenylation factors and poly(A)+ RNA binding proteins, which in turn contribute for 
mRNA clearance from the site of transcription. Nevertheless, we showed that the retained 
transcripts made by RNA Pol II LS with the Δ31 CTD are correctly polyadenylated.  
Although the mechanism via which the CTD is involved in release of the mRNA from 
the transcription site is unknown, we propose that the missing heptads in the truncated Δ31 
CTD mutant are required for binding of proteins implicated in a final co-transcriptional 
maturation of spliced and 3’ end cleaved mRNAs into export-competent ribonucleoprotein 
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particles (Figure 11). The next challenge will be to determine the proteins that are 
differentially recruited by the wild-type and the truncated CTD in order to determine which 
protein or protein complex is responsible for that final co-transcriptional maturation step that 
allows the release of the transcripts from the gene template. One good candidate to fulfil this 
role is Pcf11, a protein that is part of the 3’ end processing machinery and has recently 
emerged as a key factor in the transcription termination processs (Sadowski et al., 2003; West 
and Proudfoot, 2007; Zhang et al., 2005; Zhang and Gilmour, 2006). This protein was shown 
to associates directly with both RNA and the CTD in yeast (Zhang et al., 2005) and 
Drosophila (Zhang and Gilmour, 2006). Is able to promote the dismantle the elongation 
complexes in vitro by a CTD-dependent mechanism and is also required for transcription 
termination in vivo (Sadowski et al., 2003; West and Proudfoot, 2007; Zhang et al., 2005; 
Zhang and Gilmour, 2006).  
 
 
 
Figure 11 - A model for CTD-dependent mRNA release from the transcription site (A) 
Fully processed transcripts are released from the DNA template possibly upon recruitment of 
proteins (release factors) implicated in a final co-transcriptional maturation step of spliced and 
3’ end cleaved mRNAs into export-competent ribonucleoprotein particles. (B) The missing 
heptads in the truncated Δ31 CTD mutant are required for binding of proteins implicated in 
the release of fully processed transcripts. When an mRNA is made by an RNA Pol II with a 
Δ31 CTD these release factors are not recruited and the mRNA is retained at the transcription 
site.  
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Final considerations 
mRNA quality control mechanisms safeguard cells from the accumulation of 
malfunctioning proteins therefore modulating the clinical manifestations of many genetic 
disorders. Although a number of mRNA quality control mechanisms have been identified in 
recent years, the molecular players behind these mechanisms are still largely uncharacterised. 
In particular, it is generally unclear how these quality control systems can distinguish between 
correct and defective mRNAs and mRNP complexes. Uncovering the molecular mechanisms 
of the different mRNA surveillance pathways and understanding how these systems are 
interconnected will be a challenge for the future. Because mRNA quality control mechanisms 
modulate the clinical outcome of many genetic disorders uncovering their molecular players 
may represent promising targets for future therapeutic intervention. 
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